Table Of Content

Barrett JC, 862 Bustin M, 42 Cronise P, 757 Bartholomew R, 1470 Buzdar AU, 1797 Cunningham JE, 1629 Basse PH, 944 Bystryn JC, 1240 Curnin MGM, 849 AUTHOR Bauer HM, 997 Cuttitta F, 1470 Bauer M, 1065 Cc Cvitkovic E, 569 Beach JA, 1620 Czitrom AA, 194 INDEX Beber B, 1754 Cabanillas F, 1757 Beck WT, 1364 Cain DF, 838 D Bedi A, 876 Califano JA III, 716 Bellet RE, 648 Califano R, 1160 Dalesio O, 1024 Benedetto P, 51 Campbell H, 757 Dalton WS, 80, 105 Benedix MG, 1157 Cannon-Albright LA, 1726 Damsma O, 1408 A Benhamou E, 569 Cantor KP, 1226 Dankovic DA, 1507 Benjamin RS, 926 Caporaso NE, 64 Datta S, 1307 Benz C, 170 Carmichael J, 1748 Davidson NE, 920 Abdullah MA, 447 Berends JC, 1400 Carpenter A, 501 Davis A, 1169 Abeloff MD, 920 Berg G, 1072 Carpenter HA, 1734 Davoli E, 1160 Abildgaard N, 1391 Bergstrom R, 580 Cassady JA, 1004 DeGregorio M, 1477 Abrams JS, 1017 Berns MW, 18 Castronovo V, 29 DeJager R, 1813 Acquavella JF, 1686 Bernstein L, 1505 Cats A, 1687 Dejana E, 1321 Adami H-O, 580 Berrocal A, 449 Cavalli F, 1160 de Rooij DG, 1400 Adzick NS, 1569 Berthelsen JG, 1391 Cedermark B, 1299 Devesa SS, 369 Aebersold PM, 350, 932 Bertino JR, 24 Cederquist E, 1072 de Vries EGE, 1687 Aisner J, 1017 Beschorner WE, 133 Center MS, 1098 Dexeus FH, 285 Alberts DS, 1739 Betensky R, 1231 Cha JK, 1149 DiMagno EP, 1734 Albini A, 775 Bettelheim P, 708 Chaganti RSK, 341 Dibble SL, 1754 Alexander RB, 346 Beveridge RA, 920 Chambers AF, 485 Diener-West M, 1065 Allen PS, 1650 Beverley PCL, 609 Chambers JC, 997 D’Incalci M, 1160 Allen SL, 1017 Bhat A, 1294 Chamness GC, 1157 Dill PL, 37 Allred DC, 1477 Biggar RJ, 695 Champlin R, 576 Dionet C, 111 Aloe M, 46 Birch JM, 955 Chang M-J, 842 Divgi CR, 97 Altman N, 1754 Birrer MJ, 938 Chang Y, 640 Djuric Z, 766 Alvord WG, 1678 Bjelkengren G, 1072 Chapman JD, 1650 Dmitrovsky E, 341, 1105 Amato RJ, 285 Blair V, 955 Chapman R, 926 Dombernowsky P, 779 Ambinder R, 1176 Blaser MJ, 1734 Chase JL, 423 Donehower RC, 1778 American Medical Associa- Block G, 547 Chassagne J, 111 Dorr A, 1029, 1450 tion Council on Scientific Bloom EJ, 1500 Checkoway H, 958 Dorr RT, 1739 Affairs, 254 Bloomfield CD, 663, 1418 Chen F-M, 200 Douglass MC, 1088 Andersson M, 1013 Blot WJ, 369 Chester M, 1218 Douillard J-Y, 417 Andrulis IL, 194 Blumenthal RD, 627 Chetner MP, 1650 Dritschilo A, 480 Angus B, 281 Bobrow LG, 609 Cheung L, 1629 Drouhard T, 951 Aninipot R, 627 Boeniger M, 1686 Chiba I, 938 Duggan D, 1017 Appleton CP, 10S Boice JD, Jr, 1072 Child P, 46 Durrant LG, 866, 1245 Arencibia-Mireles O, 1085 Boldt DH, 124 Chodak GW, 329, 1346 AArrnmfaienldd JM-,P , 1566590 BBoononmeetr JAD,, 796266 CChhuy ouK C,P -H1,6 361 403 E Aronson FR, 56 Borg A, 1483 Cibas ES, 701 Arriagada R, 417 Bos! GJ, 341 Ciccone G, 362 Edelson R, 400 Arts CJ, 1347 Bosman C, 1553 Cioce V, 29 Edgerton S, 170 Aschele C, 24 Boven E, 1408, 1546, 1813 Clark GN, 124 Edwards BK, 384 Askergren J, 1299 Bowcock AM, 1085 Clark RA, 1034 Edwards J, 1294 Austin DF, 46, 849 Boyd J, 862 Clendeninn NJ, 51 Eisenhauer E, 1748 Austin EB, 1245 Boyd M, 757 Clifford CK, 299 Ellison NM, 450 Austin MA, 849 Brady JN, 1255 Coffey DS, 862 Elston RC, 65 Avis IL, 1470 Braly PS, 621 Coghlin J, 274 Enker WE, 701 Bramson J, 557 Cohen LA, 496, 1262, 1348 Ensminger WD, 1659 B Brandes LJ, 1329 Cohen SM, 880 Ensslin AS, 1564 Braunschweiger PG, 842 Collier M, 51 Epstein AL, 200 Baars JW, 1408 Brock KE, 292 Colofiore J, 1235 Ericsson U-B, 1072 Bach F, 779 Broder S, 695 Coltman CA, Jr, 1077 Erlichman C, 1169 Bachouchi M, 569 Bronzert D, 838 Comis RL, 129, 1235 Esaki Y, 1249 Baer MR, 663, 1418 Brown JM, 178 COMMIT Research Group, Eschwege F, 569 Baguley BC, 896 Brown LM, 1497 1620 Evans C, 1500 Bailey-Wilson JE, 65 Brown M, 959 Conner P, 1686 Eyre HJ, 1142, 1182 Bajorin DF, 341 Brown PD, 775 Connoliy JM, 1491 Baker LH, 926 Brownson RC, 1036 Coronado E, 1477 F Balcerzak S, 926 Bruce WR, 46 Cossman J, 980 Baldwin RW, 1245 Brunning RD, 58 Costanzi JJ, 1250 Faggiano F, 362 Bani MR, 119 Bryson P, 1748 Cowan JD, 1077 Fair WR, 294 Bannister R, 1686 Buchanin GR, 1829 Cox JD, 1065 Fajen J, 1686 Baptista J, 46 Bunni MA, 1806 Cragg G, 1294 Feillel V, 111 Baquet CR, 551 Burch PA, 294 Craig JB, 124 Feliu J, 449 Barnes S, 541 Burke TW, 1629 Cranor ML, 701 Fenoglio-Preiser C, 359, 1827 Bédron-Saura JM, 449 Burnham NL, 963 Crawford ED, 958, 1346, 1582 Ferné M, 1483 Journal of the National Cancer Institute Barrett JC, 862 Bustin M, 42 Cronise P, 757 Bartholomew R, 1470 Buzdar AU, 1797 Cunningham JE, 1629 Basse PH, 944 Bystryn JC, 1240 Curnin MGM, 849 AUTHOR Bauer HM, 997 Cuttitta F, 1470 Bauer M, 1065 Cc Cvitkovic E, 569 Beach JA, 1620 Czitrom AA, 194 INDEX Beber B, 1754 Cabanillas F, 1757 Beck WT, 1364 Cain DF, 838 D Bedi A, 876 Califano JA III, 716 Bellet RE, 648 Califano R, 1160 Dalesio O, 1024 Benedetto P, 51 Campbell H, 757 Dalton WS, 80, 105 Benedix MG, 1157 Cannon-Albright LA, 1726 Damsma O, 1408 A Benhamou E, 569 Cantor KP, 1226 Dankovic DA, 1507 Benjamin RS, 926 Caporaso NE, 64 Datta S, 1307 Benz C, 170 Carmichael J, 1748 Davidson NE, 920 Abdullah MA, 447 Berends JC, 1400 Carpenter A, 501 Davis A, 1169 Abeloff MD, 920 Berg G, 1072 Carpenter HA, 1734 Davoli E, 1160 Abildgaard N, 1391 Bergstrom R, 580 Cassady JA, 1004 DeGregorio M, 1477 Abrams JS, 1017 Berns MW, 18 Castronovo V, 29 DeJager R, 1813 Acquavella JF, 1686 Bernstein L, 1505 Cats A, 1687 Dejana E, 1321 Adami H-O, 580 Berrocal A, 449 Cavalli F, 1160 de Rooij DG, 1400 Adzick NS, 1569 Berthelsen JG, 1391 Cedermark B, 1299 Devesa SS, 369 Aebersold PM, 350, 932 Bertino JR, 24 Cederquist E, 1072 de Vries EGE, 1687 Aisner J, 1017 Beschorner WE, 133 Center MS, 1098 Dexeus FH, 285 Alberts DS, 1739 Betensky R, 1231 Cha JK, 1149 DiMagno EP, 1734 Albini A, 775 Bettelheim P, 708 Chaganti RSK, 341 Dibble SL, 1754 Alexander RB, 346 Beveridge RA, 920 Chambers AF, 485 Diener-West M, 1065 Allen PS, 1650 Beverley PCL, 609 Chambers JC, 997 D’Incalci M, 1160 Allen SL, 1017 Bhat A, 1294 Chamness GC, 1157 Dill PL, 37 Allred DC, 1477 Biggar RJ, 695 Champlin R, 576 Dionet C, 111 Aloe M, 46 Birch JM, 955 Chang M-J, 842 Divgi CR, 97 Altman N, 1754 Birrer MJ, 938 Chang Y, 640 Djuric Z, 766 Alvord WG, 1678 Bjelkengren G, 1072 Chapman JD, 1650 Dmitrovsky E, 341, 1105 Amato RJ, 285 Blair V, 955 Chapman R, 926 Dombernowsky P, 779 Ambinder R, 1176 Blaser MJ, 1734 Chase JL, 423 Donehower RC, 1778 American Medical Associa- Block G, 547 Chassagne J, 111 Dorr A, 1029, 1450 tion Council on Scientific Bloom EJ, 1500 Checkoway H, 958 Dorr RT, 1739 Affairs, 254 Bloomfield CD, 663, 1418 Chen F-M, 200 Douglass MC, 1088 Andersson M, 1013 Blot WJ, 369 Chester M, 1218 Douillard J-Y, 417 Andrulis IL, 194 Blumenthal RD, 627 Chetner MP, 1650 Dritschilo A, 480 Angus B, 281 Bobrow LG, 609 Cheung L, 1629 Drouhard T, 951 Aninipot R, 627 Boeniger M, 1686 Chiba I, 938 Duggan D, 1017 Appleton CP, 10S Boice JD, Jr, 1072 Child P, 46 Durrant LG, 866, 1245 Arencibia-Mireles O, 1085 Boldt DH, 124 Chodak GW, 329, 1346 AArrnmfaienldd JM-,P , 1566590 BBoononmeetr JAD,, 796266 CChhuy ouK C,P -H1,6 361 403 E Aronson FR, 56 Borg A, 1483 Cibas ES, 701 Arriagada R, 417 Bos! GJ, 341 Ciccone G, 362 Edelson R, 400 Arts CJ, 1347 Bosman C, 1553 Cioce V, 29 Edgerton S, 170 Aschele C, 24 Boven E, 1408, 1546, 1813 Clark GN, 124 Edwards BK, 384 Askergren J, 1299 Bowcock AM, 1085 Clark RA, 1034 Edwards J, 1294 Austin DF, 46, 849 Boyd J, 862 Clendeninn NJ, 51 Eisenhauer E, 1748 Austin EB, 1245 Boyd M, 757 Clifford CK, 299 Ellison NM, 450 Austin MA, 849 Brady JN, 1255 Coffey DS, 862 Elston RC, 65 Avis IL, 1470 Braly PS, 621 Coghlin J, 274 Enker WE, 701 Bramson J, 557 Cohen LA, 496, 1262, 1348 Ensminger WD, 1659 B Brandes LJ, 1329 Cohen SM, 880 Ensslin AS, 1564 Braunschweiger PG, 842 Collier M, 51 Epstein AL, 200 Baars JW, 1408 Brock KE, 292 Colofiore J, 1235 Ericsson U-B, 1072 Bach F, 779 Broder S, 695 Coltman CA, Jr, 1077 Erlichman C, 1169 Bachouchi M, 569 Bronzert D, 838 Comis RL, 129, 1235 Esaki Y, 1249 Baer MR, 663, 1418 Brown JM, 178 COMMIT Research Group, Eschwege F, 569 Baguley BC, 896 Brown LM, 1497 1620 Evans C, 1500 Bailey-Wilson JE, 65 Brown M, 959 Conner P, 1686 Eyre HJ, 1142, 1182 Bajorin DF, 341 Brown PD, 775 Connoliy JM, 1491 Baker LH, 926 Brownson RC, 1036 Coronado E, 1477 F Balcerzak S, 926 Bruce WR, 46 Cossman J, 980 Baldwin RW, 1245 Brunning RD, 58 Costanzi JJ, 1250 Faggiano F, 362 Bani MR, 119 Bryson P, 1748 Cowan JD, 1077 Fair WR, 294 Bannister R, 1686 Buchanin GR, 1829 Cox JD, 1065 Fajen J, 1686 Baptista J, 46 Bunni MA, 1806 Cragg G, 1294 Feillel V, 111 Baquet CR, 551 Burch PA, 294 Craig JB, 124 Feliu J, 449 Barnes S, 541 Burke TW, 1629 Cranor ML, 701 Fenoglio-Preiser C, 359, 1827 Bédron-Saura JM, 449 Burnham NL, 963 Crawford ED, 958, 1346, 1582 Ferné M, 1483 Journal of the National Cancer Institute Ferrone S, 1307 Goedert JJ, 695 Hebert JR, 872 Jensen OM, 1581 Feun LG, 51, 1250 Goldenberg DM, 78, 527 Heilbrun LK, 766 Jessen CR, 1226 Fine S, 1169 Goldenberg SK, 1386 Henderson BE, 63, 1182, 1820 Jiang FN, 1218 Finkel HE, 1421 Goldfarb RH, 944 Henderson BR, 1103 Jiang H, 1307 Fisher B, 1278 Goldgar DE, 1726 Henderson IC, 894 Jiang S, 1218 Fisher PB, 1307 Goldman E, 170 Henderson MM, 1260 Jicha DL, 350, 769 Fivenson DP, 1088 Goldson AL, 1758 Hennessy C, 281 Johansen B, 1391 Flehinger BJ, 243, 1112 Gonzdlez-Barén M, 449 Henry JA, 281 Johansson BR, 944 Fletcher JG, 1316 Gordon GB, 876, 920 Henson DE, 443, 547 Johnson CS, 842 Fletcher WS, 926 Gotay CC, 212 Herberman RB, 433, 944 Johnson ES, 1337 Fodsiad @, 1020, 1419 Gottesman MM, 565, 1307, Hersh EM, 1250 Johnson NJ, 1659 Fogler WE, 1386 1386 Hesketh PJ, 613 Johnson S, 932 Fonck Y, 111 Govindarajan S, 1820 Hickey E, 170 Johnston D, 1240 Fonk JCM, 1408 Graham GM, 1307 Hill SM, 1157 Johnston JB, 42 Ford LG, 1450 Gralla R, 97 Hines K, 932 Jones MP, 429 Forde KA, 359, 1827 Grant P, 1763 Hirano T, 1668 Jordan VC, 492, 1488 Forman AD, 1797 Gray-Goodrich M, 757 Hirayama R, 1249 Forman D, 1702 Green MR, 382 Hirokawa K, 1249 K Formby B, 1564 Greenberg RS, 849 Hirte H, 1748 Forrest AP, 581 Greene GL, 1157 Hiscott J, 557 Kabat GC, 872 Fossel ET, 1316 Greene MH, 1720 Hjalgrim H, 1391 Kaizer H, 58 Franceschi S, 139 Greenwald P, 551 Hjalmar M-L, 1299 Kamen BA, 1829 Franks CR, 1408 Grever MR, 1294 Hoekman K, 1546 Kandel R, 194 Fraumeni JF, Jr, 369 Gridley G, 292 Hoffman J, 1235 Kane SE, 565 Freedman LS, 299 Grigg W, 721 Hohn DC, 423 Kaneko Y, 1668 Freeman H, 526 Grigioni WF, 29 Hoifgdt HK, 1020 Kaplowitz LG, 139 Freireich EJ, 829 Grillo F, 1553 Hollingsworth R, 1349 Karp JE, 443, 1450 Fridman R, 769 Grobman BJ, 423 Hollingsworth RE, 91 Karsai H, 190 Friedenreich CM, 336 Grogan TM, 80 Holm L-E, 1072 Kasprzyk PG, 1470 Friedman MA, 16, 838 Groshen S, 63 Holmberg L, 580 Katzenellenbogen BS, 1434 Fritz NF, 1488 Gruys E, 1386 Holmes EC, 228 Kavanagh JJ, 1629 Frustaci S, 1160 Grzegorzewski K, 1149 Holmes FA, 1797 Kefford RF, 1103 Frye DK, 1797 Guarini L, 1307 Hong WK, 1110, 1111 Keller JB, 1231 Fujisue M, 1743 Gumbart C, 1077 Hoover RN, 1497 Keller JR, 1672 Fujita J, 1668 Gumbrell L, 1160 Hopfner M, 708 Kendall ME, 496, 1262, 1348 Fukatsu A, 1668 Gurgin V, 46 Horm JW, 551, 695 Kennedy KA, 632 Fukumoto M 1668 Gurpide E, 40S Horn T, 1176 Kennedy MJ, 920 Fukuoka M, 855, 1164, 1743 Horowitz ME, 1460 Kern F, 716 Fukuyama H, 1668 H Hortobagyi GN, 1797 Kessel MAP, 1813 Fuqua SAW, 1157 Horwitz JP, 1508 Key C, 849 Furmanski P, 842 Haas OA, 708 Horwitz SB, 288 Keyes SR, 632 Furuse K, 855 Hainesworth JD, 1757 Hose C, 757 Khokha R, 485 Haisma HJ, 1813 Hossan E, 285 Kiang DT, 462 G Hakulinen T, 579 Howard BH, 565 Kibbey MC, 769 Hall EJ, 156 Howe GR, 336, 1035, 1505 Kim J-H, 938 Gail MH, 695 Hall P, 1072 Howell SB, 621 Kim J-P, 938 Gandara DR, 613 Hallahan DE, 480 Hruban RH, 1024 Kim S, 621 Gann PH, 274 Hallquist A, 1072 Hsieh C, 1324 Kimmel M, 701 Gannon JE, 116 Halperin W, 501 Hsu G, 1182 Kimura N, 1249 Garbisa S, 29 Halpert RD, 1034 Hu XF, 206 Kirmani S, 621 Garbowski GC, 359, 1827 Hammond SK, 274 Hudes GR, 1235 Kjgnniksen I, 1020 Garewal H, 1111 Hande KR, 1523 Hui KKS, 1316 Kleibeuker JH, 1687 Garofalo A, 119 Handley FG, 1294 Hutchins LF, 1077 Klein MK, 18 Gause BL, 1149 Hankey BF, 384 Hutchinson M, 557 Kleinman HK, 769, 1509 Gazdar AF, 938 Hanlon J, 51 Hyatt C, 932 Knol JA, 1659 Gazzaniga JM, 429 Hansen EB, 200 Knutsen CA, 1659 Geissler K, 708 Hansen SO, 1391 Koeller J, 124 Geleziunas R, 557 Harada K, 186 Kolonel L, 849 Gerber G, 1346 Harman G, 124 Iga H, 186 Komschlies K, 1386 Gerber GS, 329 Harper GR, 447 Ikegami H, 855 Kondo Y, 186 Gerhardsson de Verdier M, Harris M, 955 Isaacs JT, 346 Konrad M, 129 1505 Harris WF, 1294 Isacson P, 849 Koong A, 178 Getzenberg RH, 862 Harrison MR, 1569 Isonishi S, 621 Kopecky KJ, 1250 Giavazzi R, 119 Harrison SD, Jr, 1509 Kopp WC, 1678 Gibbs T, 551 Hartley AL, 955 J Kopper L, 1174 Giffen CA, 1620 Haskell CM, 314 Kopriva D, 557 Gilpin E, 1009 Haut M, 712 Jacobsen SEW, 1672 Korcak L, 932 Giovino G, 1009 Havelec L, 708 Jain M, 336 Koski B, 1748 Glas U, 1299 Havlin KA, 124 Jain RK, 433 Koutsky L, 978 Glasgow RE, 1620 Hawkins MM, 1643 James WH, 1420 Kovach JS, 2, 791, 1004 Glass A, 368 Hay K, 46 Jane JA, 880 Kovacs TOG, 1470 Glazer E, 46 Hayes HM, 1226, 1497 Javadpour N, 1497 Kramer BS, 1450, 1636 Glazer RI, 42 Haywood L, 627 Jazmaji V, 46 Kreis W, 725 Goates J, 640 Heald P, 400 Jenkins J, 1412 Krigel RL, 129 Vol. 83, No. 24, December 18, 1991 AUTHOR INDEX 1849 Kris M, 97 Looijenga LHJ, 1400 Miaskowski C, 1754 O Krull EA, 1088 Loomis M, 18 Michelson S, 1574 Kudoh S, 1164, 1743 Loprinzi CL, 450, 963 Mick R, 1560 O’Clock GD, Jr, 116 Kufe DW, 480 Loschiavo SR, 212 Miles VA, 1149 O’Connell G, 1748 Kuhn JG, 124 Lote K, 1092 Miller AB, 336, 1111 O’Connell KJ, 1497 Kurashima C, 1249 Lotze M, 932 Miller LL, 1412 O’Dwyer PJ, 1235 Kusunoki Y, 1164, 1743 Lubin MB, 1831, 1832 Miller RW, 1341 Offerhaus GJ, 1024 Kuwano H, 1395 Luboinski B, 569 Miller TP, 105 Olden K, 1149 Kwiatkowski F, 111 Ludwig H, 708 Mills PK, 1037 O’Malley BW, 1157 Kyprianou N, 346 Lum BL, 682 Mills S, 1009 Olsen JH, 1581 Lundell G, 1072 Minford J, 1017 Olsson H, 1483 L Lung Cancer Study Group, Minna JD, 938 Oosterhuis JW, 1400 266 Mishima Y, 1249 Ordéfiez A, 449 Lababidi MK, 492 Lynch CF, 429 Moench T, 576 Oredipe OA, 1149 LaBella FS, 1329 Lynch HT, 951 Moller H, 1581 Ortaldo JR, 646 Laberge F, 1169 Lynch J, 951 Monks A, 757 Osborne CK, 1077, 1477 Lacombe-Terrier M-J, 417 Lynch PM, 951, 1688 Mooi WJ, 1024 Osoba D, 190, 1169 La Creta FP, 1235 Lyte M, 116 Moore D III, 170 Msterlind A, 1391 Lad&nyi A, 1174 Mori M, 1395 Ozer H, 1413 Laerum OD, 1092 M Morino H, 1743 Ozols RF, 1235 Lamers W, 1500 Morita M, 1395 Lamki L, 1629 Malapetsa A, 557 Morris DL, 866 P Landry J, 170 Manos MM, 997 Morris JS, 292 Langan-Fahey S, 492, 1488 Marcus S, 1009 Morris L, Jr, 722 Padavic-Shaller KA, 129 Lange PH, 1199 Markowitz S, 501 Morrison AS, 226 Padmanabhan R, 565 Langley J, 757 Markowitz SD, 712 Morton JF, 138 Paffenbarger RS, Jr, 1324 Lanspa S, 951 Marquardt D, 1098 Mosley K, 105 Paganini-Hill A, 1182 Lantz PM, 1540 Marsden HB, 955 Motzer RJ, 341 Page DL, 648 Laplanche A, 417 Martin DS, 1235 Moulton TA, 1307 Page R, 190 Larson S, 1602 Martin GR, 769 Mouridsen HT, 1013 Paik S, 716 Larson SM, 97 Martin M, 417 Mulé JJ, 350 Pajak TF, 1065 Larsson L-G, 1072 Martin-Padura I, 1321 Mulshine JL, 1470 Palmer C, 951 Latreille J, 1169 Martini F, 511 Mulvihill SJ, 423 Palmer JR, 355, 1183 Laurensse E, 437 Martino S, 766, 1077 Munck J-N, 569 Panasci L, 557 Lauri D, 1321 Martens HJM, 1813 Munck-Hansen J, 1391 Pannacciulli I, 511 La Vecchia C, 139, 1181 Mason-Liddil N, 1739 Muquardt C, 1553 Park J-G, 938 Lawrence TS, 507 Masuda N, 1164, 1743 Murray D, 1028 Parkin JD, 206 Le Boit PE, 56 Matsuda H, 1395 Murray JL, 1629 Parnes HL, 1017 Le Chevalier TL, 417 Matsui K, 1164, 1743 Murray N, 190 Parsa NZ, 341 Lechner K, 708 Mattsson A, 1299 Murray TI, 1827 Parsonnet J, 640 Leclercq G, 1553 May FEB, 281 Pastan I, 565, 1386 Ledermann JA, 609 Mayall B, 170 Pater J, 1169 Lee H-D, 938 Mayer RJ, 806 N Paul M, 274 Lee I-M, 1324 Mayo J, 757 Paull K, 757 Lee WC, 359 Mazurka J, 1748 Nadal JC, 437 Pearson FC, 37 Lee W-H, 91, 637, 1349 McClay EF, 621 Nagourney RA, 1418 Pearson JW, 1386 Lennard TWJ, 281 McClure S, 1077 Nagy P, 1174 Pechacek TF, 1142 Levi F, 1181 McCoy CB, 1754 Nakagawa K, 1743 Pennock GD, 105 Levin L, 1748 McCurnin DM, 1226 Nakayama H, 1668 Perbeck L, 1299 Levine AM, 662 McDonagh J, 1316 Nannmark U, 944 Percy CL, 384 Levine M, 547 McGovern RM, 1004 Naquin M, 1009 Perez-Perez GI, 1734 Levy JG, 1218 McGuire DB, 134 Natale A, 627 Peters GJ, 437 Levy RL, 212 McGuire WL, 154, 1157 Natale RB, 1250 Peterson J, 1413 Lewis BJ, 423 McKeown-Eyssen GE, 46 Nayfield SG, 1450 Pfister DG, 341 Ley C, 997 McMahon BJ, 916 Needham L, 1321 Phillips JG, 1739 Li CC, 46 McPhee MS, 1650 Negoro S, 1164, 1743 Piantadosi S, 266 Li GF, 46 McQuillan A, 557 Neidhart J, 1077 Piccart MJ, 1553 Li S, 637 McSharry JJ, 447 Neugut AI, 359, 1827 Piekarski J-D, 569 Liao SH, 51 McTiernan A, 849 Neumann RD, 507 Pienta KJ, 862 Lidberg M, 1072 McWhorter WP, 1182 Neun JL, 645 Piepkorn MW, 1726 Lindberg S, 1072 Mee D, 46 Newcomb PA, 260, 1540 Pierce JP, 1009 Linkesch W, 708 Meeker BE, 1650 Newton LK, 1797 Pihl A, 1020 Liotta LA, 29, 775 Meissonnier F, 111 Neyndorff H, 1218 Pike MC, 63, 1505, 1763 Lippman ME, 716 Melamed MR, 701 Nicolin A, 24 Pinedo HM, 437, 1408, 1546, Lippman SM, 1110, 1111 Melchiori A, 775 Nielsen BB, 1754 1813 Little C, 190 Melder RJ, 433 Niitani H, 1164 Pirker R, 708 Liu DJ, 1218 Mellemgaard A, 1581 Nijman HW, 1408 Pirotte P, 1553 Lofters W, 1169 Mendelsohn J, 97 Nisen PD, 1085 Plagne R, 111 Logothetis CJ, 285, 786 Merchant B, 97 Nishioka M, 1743 Plaizier ABD, 1813 Lokich J, 1585 Meschter CL, 496, 1491 Nishiwaki Y, 855 Planner RS, 1763 London §S, 1505 Messina M, 541 Nomura AMY, 1403 Platz CE, 429 London T, 916 Metch B, 926 Nordlund JJ, 1088 Plaxe SC, 621 Longaker MT, 1569 Meyer LJ, 1726 Normolle DP, 1659 Plezia P, 105 Longo DL, 1386, 1672, 1678 Meyskens F, Jr, 1111 Nowell PC, 1061 Plezia PM, 1739 Journal of the National Cancer Institu.— Pluda JM, 695 Ryan J, 926 Smart CR, 1636 Tellez-Bernal E, 569 Polednak AP, 1679 Smith MA, 1460 Tennvall J, 1072 Pomaranski M, 1088 S Smith TJ, 139 Terrio P, 1659 Pontén J, 580 Smith JW II, 1678 Testa JE, 740 Portlock CS, 1106 Smithgall TE, 42 Theriault RL, 1797 Saijo N, 855 Pottern LM, 1497 Snader K, 1294 Theve T, 1299 Sakmar E, 1659 Pratt CB, 880 Sobel ME, 29 Thijssen JHH, 1347 Salmon SE, 105 Prieskorn D, 1659 Sobrero A, 24 Thomas DB, 849 Samaniego F, 341 Priest DG, 1806 Soletormos G, 779 Thompson L, 1629 Samson MK, 1250 Pritikin J, 640 Somell A, 1299 Thompson M, 1488 Sanders M, 932 Sommer SS, 1004 Thompson RS, 1260 Q Santi L, 775 Soderlind K, 1650 Thompson WD, 849 Saracci R, 1362 Sondik EJ, 695, 1829 Thor A, 170 Quigley JP, 740 Sartor O, 877 Souhami RL, 609 Timmins D, 1763 Quoix E, 4174 Sartorelli AC, 632 Sparén P, 580 Tong MJ, 1820 Sasaki A, 433 Speyer JL, 1682 Topalian S, 932 Satariano W, 849 R Spicer DV, 63, 1763 Tormey DC, 1488 Sato M, 186 Sridhar KS, 51 Torok N, 1174 Savaraj N, 51 Stadtmauer E, 1254 Torti FM, 682 Raber MN, 1797 Sawai S, 1249 Stagg RJ, 423 Travis WD, 350 Rabkin CS, 695 Scanziani E, 119 Stalsberg H, 849 Treat MR, 359, 1827 Ranstam J, 1483 Schepartz SA, 1294 Staunton MR, 56 Treston AM, 1470 Rasmussen LH, 1391 Scheper RJ, 1408 Steakley C, 645 Trimble L, 1650 Ratain MJ, 1560 Scherrer R, 708 Steeg PS, 712 Tsuruo T, 565, 1386 Rayner AA, 423 Schiffman MH, 997 Steenland K, 1380 Tuck AB, 485 Reading BA, 766 Schlegel R, 980 Stefanek M, 1254 Tujimoto H, 186 Real FX, 97 Schmitz JC, 1806 Steinfeld J, 1126 Recondo G, 569 Schmookler BM, 29 Reddy PG, 1307 Schneider RJ, 721 Steis RG, 1678 U Stemhagen A, 849 Redmond C, 1278 Scholes D, 260 Stemmermann GN, 1403 Reif AE, 64 Schottenfeld D, 243, 1112 Ueland PM, 1092 Stephens RL, 1077 Reingold A, $97 Schutte SE, 1400 Unger M, 97 Stern M, 1569 Remick SC, 447 Schutz M, 958 Ungerleider RS, 16, 1460 Stern R, 1569 Remington PL, 1540 Schwartz L, 170 Urba WJ, 1678 Stetler-Stevenson WG, 775 Reuter VE, 341 Schwartz PE, 637 Usui N, 1386 Stetson PL, 1659 Rheins LA, 1088 Schwartz R, 124 Utsuyama M, 1249 Stobbe CC, 1650 Richardson RC, 1226 Schweighart S, 97 Uzych L, 368, 1589 Stolinsky DC, 1589 Richman §, 51 Schweitzer J, 1294 Stolley PD, 355 Ries LA, 384 Scudiero D, 757 Storer BE, 260 v Riggs CW, 1386 Scully MC, 56 Storm HH, 1013 Rinehart JJ, 1250 Seifter EJ, 208, 1831 4 Streicher HZ, 1340 Vaigro-Wolff A, 757 Ringborg U, 1299 Seligman PA, 1582 Streicher R, 1686 Valent P, 708 Ringel I, 288 Sella A, 285 Struck RF, 1739 Valentino L, 58 Roberts D, 501, 1686 Sellers TA, 65 Stuart RK, 1806 Valeriote FA, 766 Roberts WG, 18 Sessa C, 1160 Stutzman RE, 1497 van den Berg H, 1347 Robins RA, 1245 Severson RK, 1028 Suemasu K, 855 van Dissel-Emiliani FM, 1400 Rockwell S, 632 Shackney SE, 1105 Sugimachi K, 1395 van Groeningen CJ, 437, Rodenhuis S, 1024 Shah A, 190 Sukhatme V, 480 1408, 1546 Rodriguez E, 341 Shambaugh E, 384 Sulkes A, 1160 Van Nevel P, 1421 Roe DJ, 1739 Shanken LJ, 1629 Svardal AM, 1092 Vandersteen D, 640 Roeske WR, 105 Shapiro S, 355, 1183, 1522 Swanson C, 1340 van Muijen M, 1813 Roh JK, 938 Sharkey RM, 627 Swanson SK, 1004 Vaughan CB, 1077 Roh M, 423 Sherman ML, 480 Sweeney TM, 769 Veenstra S, 1553 Rolland-Portal I, 1181 Shimada N, 1249 Venock AP, 423 Roos JC, 1813 Shimoyama M, 855 Rose DP, 496, 1491 Shmookler BM, 29 T Vermorken JB, 1408, 1546 Verrelle P, 111 Rosenberg L, 355, 1183 Shoemaker R, 757 Vilcek J, 807 Rosenberg SA, 350, 932 Shopland DR, 1142 Taghizadeh K, 274 Vineis P, 362 Rosenblatt KA, 849 Shoupe D, 1763 Taguchi T, 1164 Vistica D, 757 Rosenblum MG, 1629 Sibley RK, 640 Tait N, 1017 Vogelstein B, 1004 Rosenthal JF, 1497 Sidransky D, 785 Takada M, 1164, 1743 Voigt LF, 260 Ross JS, 447 Sigurdsson H, 1483 Takagi Y, 1249 Vokes EE, 785 Ross RK, 1182 Sikic BI, 738 Takahashi T, 938 Volker K, 1386 Rosso R, 24 Silbergeld EK, 1198 Takenawa J, 1668 Von Hoff DD, 124 Rothschild H, 65 Silva EG, 1629 Takifuji N, 1164, 1743 Rotstein S, 1299 Simon R, 1261, 1460 Talley NJ, 1734 Rowinsky EK, 1778 Sizer B, 580 Tamura T, 855 Ww Rowley SD, 920 Skehan P, 757 Tannenbaum SR, 274, 1507 Royce LS, 769 Skipper PL, 274 Tarayre M, 417 Waber PG, 1085 Ruckdeschel JC, 447 Skolnick MH, 1726 Tarone RE, 1226, 1497 Wagstaff J, 1408, 1546 Rudolph AA, 129 Skoog L, 1299 Tashiro CJ, 997 Wainberg MA, 557 Ruffie P, 417 Slamon DJ, 229 Taylor CR, 200 Walczak J, 1235 Ruscetti FW, 1672 Slate D, 1574 Te V-C, 1181 Wall DM, 206 Rusthoven J, 1169, 1748 Slebos RJC, 1024 Teare MD, 955 Wallner J, 708 Rutqvist LE, 1299 Smaaland R, 1092 Tedeschi M, 362 Walsh JH, 1470 Vol. 83, No. 24, December 18, 1991 AUTHOR INDEX Walters RS, 1797 Weldy S, 18 Wilson JD, 1686 Yeh SD, 97 Waiz N, 1650 Wellstein A, 716 Willson JKV, 712 Yeung KS, 46 Ward EM, 501, 1380, 1507, Welsch CW, 300, 1262 Wilson K, 1169 Yoshida H, 186 1686 Welt S, 97 Wilson SM, 485 Yoshida O, 1668 Wargovich MJ, 951, 1688 Wencyk PM, 866 Wiltrout RH, 1386 Young BE, 260 Warr D, 1169 West D, 849 Winawer SJ, 243, 1034, 1112 Young JD, 129 Warren RS, 423 Westley BR, 281 Winograd B, 1160 Yu MC, 1820 Warrington RC, 1329 Weston A, 1682 Wohlganger J, 1585 Yura Y, 186 Warshauer ME, 355 Wharton JT, 1629 Wolchok JD, 807 Watson AL, 866 White E, 1260 Wold LE, 1004 Watson SA, 866 White SL, 1149 Wu JM, 963 Z Waye JD, 359, 1827 Whitehead RP, 1250 Wu RS, 838 Weadock KS, 627 Whiteside TL, 433 Wunder JS, 194 Zain M, 769 Weaver A, 1734 Whittemore AS, 1231 Wynder EL, 475 Zalcberg JR, 206 Weber LA, 170 Wibault P, 569 Zalupski M, 926 Weerasiri T, 1763 Wicklund H, 1072 Zang E, 496, 1262 Weichselbaum RR, 480 Wiebe V, 1477 Y Zang F, 1348 Weiden PL, 266 Wiebelt H, 579 Zauber AG, 355 Wein S, 1348 Wiklund K, 1072 Yanagawa T, 186 Zeiger E, 1177 Weiner LM, 129 Wilding G, 365 Yang J, 932 Zhu SL, 46 Weisenthal LM, 37, 790 Wilking N, 1299 Yang Z, 1659 Zinsmeister AR, 1734 Weiss GR, 124, 926 Willian A, 1169 Yang-Feng TL, 637 Zone JJ, 1726 Weiss NS, 260 Willett WC, 292, 1035 Yannelli JR, 769 Zucchetti M, 1160 Weitman SD, 1829 Willingham MC, 565 Yarchoan R, 695 Zugmaier G, 716 A Public Service of the Forest Service, ONLY YOU CAN PREVENT FOREST FIRES. © a USDA, and your State Foresters. Journal of the National Cancer Institute progress in development of (1971-1991), 1370 screen, high-flux, using diverse panel of cultured human tumor SUBJECT cell lines, feasibility of, 757 effects of food components, 163 Antiemetic agents, serotonin antagonists as (review), 613 INDEX Antiestrogen resistance, breast cancer cell mechanism for undermin- ing effectiveness of endocrine therapy (editorial), 1434 Antifolates, rapid development of resistance in vitro, clinical implica- tion, 24 Antigens lung cancer, results of second international workshop (commentary), 609 A Thy-1 and T-cell receptor expression in mycosis fungoides and benign inflammatory dermatoses, 1088 Acquired immunodeficiency disease see also Human immuno- tissue polypeptide, activity in cerebrospinal fluid, marker of breast deficiency virus cancer metastases, 779 cimetidine treatment of Kaposi’s sarcoma in, pilot study, 139 Anti-inflammatory drugs, nonsteroidal, and incidence of large-bowel non-Hodgkin’s lymphoma incidence, 232, 695 cancer, 355 recommendations of National Commission, 1449 Antineoplastic drugs, combined with intracellular histamine an- Activism, cancer patient, 528 tagonists, therapeutic index, 1329 Adenocarcinoma Antitumor activity, biological response modifiers (editorial), 2 colon Aphidicolin glycinate, phase I and clinical pharmacological evalua- cell resistance to antifolates in vitro, 24 tion of, 1160 intestinal- and diffuse-type gastric, Helicobacter pylori infection Applications of Diffusion Theory to Cancer Care in the United States in, 640 (book review), 959 laminin receptor expression in, 29 Asbestos, and colorectal adenomatous polyps and cancer, 1827 gastric, Helicobacter pylori infections and, 640, 1702, 1734 Ascorbic acid lung (human), K-ras oncogene activation and smoking, relationship protection against cancer, 396 in, 1024 biologic functions and relation to cancer (commentary), 547 metastatic, cyclophosphamide doxorubicin, fluorouracil, and Aspirin leucovorin for, 1017 beta-carotene and vitamin E cancer prevention study for women, Adolescents, tobacco use by high school students, 1615 1531 Adrenal corticosteroids, protection of central nervous system metas- large-bowel cancer incidence in California retirement community, tases from systemic chemotherapy by, 648 1182 Advances in Cancer Control: Screening and Prevention Research— prevention trials for women smokers, 681 Progress in Clinical and Biological Research (book review), 443 Atlas of Bone Marrow Pathology (book review), 58 Age and cancer mortality, 811 B and pap smear rates, 989 Aging, and cancer, 471 Agreements, to test foods for cancer prevention, 1050 Ballplayers, smokeless tobacco cessation project for, 1215 AIDS see Acquired immunodeficiency disease Basic Mechanisms: Progress in Clinical and Biological Research AIDS Vaccine Research and Clinical Trials (book review), 1340 (book review), 876 Alpha-tocopherol, prevention trials for women smokers, 681 Beryllium American Association for Cancer Research, clinical application of and lung cancer (editorial), 1362 research findings emphasized at, 819 disease, lung cancer among patients with, cohort mortality study, American Association for the Advancement of Science, aging and 1380 cancer discussions, 471 Beta-carotene American Cancer Society, funding for grants, 90 aspirin and vitamin E cancer prevention study for women, 1531 American Society of Clinical Oncology, new frontiers in cancer re- prevention of cancer, 1110 search, 821 prevention trials for women smokers, 681 4-Aminobipheny! hemoglobin adducts, in fetuses exposed to tobacco Biological diversity, and drug development (commentary), 1294 smoke in utero, 274 Biological response modifiers Aniline, bladder cancer in workers exposed to, 501, 1507, 1686 effective use of (editorial), 2 Animal research immunopotentiating, effect of prior cancer chemotherapy on human chimpanzees and libel suit, 1589 tumor-specific cytotoxicity in vitro in response to, 37 exotic species in, 1438 prior chemotherapy and activity of, 790 regulations, 1436 progress in research (1971-1991), 530 Anorexia, cancer-related, treatment with megestrol acetate, optimal Biology of Hematopoiesis: Progress in Clinical and Biological Re- dose, 449 search (book review), 876 Antibodies see Monoclonal antibodies Biomarkers, advances in chemoprevention research, 1369 Anticancer Biomedical research drug Institute of Medicine recommendations to NIH, 4 discovery (editorial), 738 issues addressed at congressional reauthorization hearing, 608 monitoring during therapy (editorial), 1523 U.S. leadership in, 393 Vol. 83, No. 24, December 18, 1991 SUBJECT INDEX 1853 Biopsies, breast, defensive, 1207 Diet for a Poisoned Planet: How to Choose Safe Foods for You and Biotechnology, progress in, 6, 1608 Your Family, 721 Bisantrene, with doxorubicin and mitoxantrone in advanced breast Diet, Life-Style, and Mortality in China: A Study of the Charac- cancer, 1077 teristics of 65 Chinese Counties, 1340 Bladder cancer Effects of Therapy on Biology and Kinetics of the Residual Tumor, advanced transitional cell carcinoma, gallium nitrate treatment, 1582 Part A: Pre-Clinical Aspects—Progress in Clinical and Biologi- in situ distinguished from invasive, surveillance problems (editorial), cal Research, 1105 384 Effects of Therapy on Biology and Kinetics of the Residual Tumor, invasive, registry problems in classifying, 429 Part B: Clinical Aspects—Progress in Clinical and Biological Re- piritrexim capsules using prolonged, low-dose oral administration, search, 1105 phase I clinical trials, 51 Environmental Genotoxicity, Risk, and Modulation: Progress in superficial, adjuvant intravesicular pharmacotherapy for (review), Clinical and Biological Research, 876 682 Extremely Low Frequency Electromagnetic Fields: The Question of workers exposed to ortho-toluidine and aniline, 501, 1507, 1686 Cancer, 1028 Blue Cross/Blue Shield, autologous bone marrow transplant coverage, Familial Cancer, 1830 Flow Cytometry and Sorting, Second Edition, 133 12 Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treat- Bone marrow ment, 576 glutathione in, and circadian stage relation to DNA synthesis, 1092 Hematopoietic Growth Factors in Clinical Applications, 1412 proliferation, protective effects of swainsonine during cytotoxic Hereditary Cancer and Preventive Surgery, 1829 chemotherapy, 1149 Hodgkin’ sD isease: The Consequences of Survival, 1106 registries, growth of, and patient survival, 988 Human Retroviruses: UCLA Symposia in Molecular and Cellular transplants Biology, 1255 autologous, for breast cancer treatment, 12, 894, 920 Introduction to Radiobiology, 1028 cancer treatment with, 388 Leukaemia Diagnosis: A Guide to the FAB Classification, 443 insurance coverage of trials, 1136 Malignant Lymphoma: Biology, Natural History, and Treatment, quality of life evaluated in trials, 1137 1757 Bone Marrow Transplantation (book review), 1500 Management of Pain, Volumes I and II, 208 Bone Marrow Transplantation in Children (book review), 58 Manual of Clinical Oncology, 722 Bone sarcomas, alterations in retinoblastoma gene and tumor grade, Metabolism, Testing Methods, and Chromosomes: Progress in Clini- 194 cal and Biological Research, 876 Bone Tumors: Clinical, Radiologic, and Pathologic Correlations Molecular Genetics in Cancer Diagnosis, 877 (book review), 208 Mutagens and Carcinogens in the Diet, 1177 Book reviews Natural Killer Cells: Biology and Clinical Application, 646 Advances in Cancer Control: Screening and Prevention Research— Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Progress Progress in Clinical and Biological Research, 443 in Clinical and Biological Research, 786 AIDS Vaccine Research and Clinical Trials, 1340 Neoplastic Diseases of the Blood, 1829 Applications of Diffusion Theory to Cancer Care in the United Neuro-Oncology: Primary Malignant Brain Tumors, 294 States, 959 New Aspects in the Diagnosis and Treatment of Hodgkin’ s Disease: Atlas of Bone Marrow Pathology, 58 Recent Results in Cancer Research, 1176 Basic Mechanisms: Progress in Clinical and Biological Research, New Strategies in Bone Marrow Transplantation, 1254 876 Non-Hodgkin’ sL ymphomas, 208 Biology of Hematopoiesis: Progress in Clinical and Biological Re- Occupational Cancer Epidemiology, Recent Results in Cancer Re- search, 876 search, 958 Bone Marrow Transplantation, 1500 On Death Without Dignity: The Human Impact of Technological Bone Marrow Transplantation in Children, 58 Dying, 1500 Bone Tumors: Clinical, Radiologic, and Pathologic Correlations, Oncogenes and the Molecular Origins of Cancer, 785 208 Oncology Nursing Advances, Treatments, and Trends Into the 21st Cancer: Causes, Occurrence, and Control, 1341 Century, 1412 Cancer Chemotherapy: Principles and Practice, 208 Prostate Cancer and Testicular Cancer: Progress in Clinical and Cancer Experience: Nursing Diagnosis and Management, 134 Biological Research, 365 Cancer Growth and Progression, 208 Race Is Run: One Step at a Time, 1254 Cancer Imaging with Radiolabeled Antibodies: Cancer Treatment Radiation Oncology: Radiobiological and Physiological Perspec- and Research, 507 tives, 507 Cancer Nursing: Principles and Practice, 645 Regional Antineoplastic Drug Delivery in the Management of Cancer of the Skin, 1176 Malignant Disease, 1682 Cancer Treatment, 1757 Retrovirus Biology and Human Disease, 576 Carcinogenesis: Progress in Clinical and Biological Research, 876 Role of High Energy Electrons in the Treatment of Cancer, 1758 Carcinomas of the Head and Neck: Cancer Treatment Research, Somatic and Heritable Mutation, Adduction, and Epidemiology: 785 Progress in Clinical and Biological Research, 876 Chronic Myelogenous Leukemia: Molecular Approaches to Re- Temporal Control of Drug Delivery, 1585 search and Therapy, 1413 Treatment of Early Breast Cancer: Worldwide Evidence, 1985-1990, Complex Mixtures and Cancer Risk, 1682 1029 Current Genitourinary Cancer Surgery, 294 Treatment of Prostatic Cancer: Facts and Controversies—Progress Detection and Treatment of Early Breast Cancer, 721 in Clinical and Biological Research, 365 Journal of the National Cancer Institute Triumph: Getting Back to Normal When You Have Cancer, 1585 segregation analysis of, histopathologic data, 648 Uro-oncology: Current Status and Future Trends, 958 stress response protein determination in primary carcinomas, clini- Brain cal, histologic, and prognostic correlations, 170 cancer incidence time trends in Connecticut, 1679 studies, combined analysis of, 1505 mapping, space imaging technology applied to, 986 surgery trends, 1607 Breast see Mammary for animal studies taxol efficacy, 11 biopsies, defensive, 1207 treatment, very-high-dose chemotherapy with autologous bone mar- imaging, 1444 row transplantation, 894, 920 Breast cancer advanced breast self-examination and, 260 C doxorubicin, bisantrene, and mitoxantrone in, 1077 recombinant human granulocyte macrophage colony-stimulating California factor, and chemotherapy-induced myelosuppression, 1546 aspirin use and large-bowel cancer incidence in retirement com- antiestrogen resistance as cell mechanism for undermining effective- munity, 1182 ness of endocrine therapy (editorial), 1434 non-Asians of Los Angeles County, non-viral risk factors for autologous bone marrow transplant treatment, 12 hepatocellular carcinoma in, 1820 awareness month, 1449, 1534 Camptothecin, CPT-11 derivative for treatment of advanced non— chemoprevention, readiness for (editorial), 462 small-cell lung cancer, 1164 coalition, 756 Cancer see also specific sites, histological sites, Tumor congressional attention to, 996 advanced malignancies contralateral, tamoxifen as preventive agent, 1278, 1299 piritrexim capsules using prolonged, low-dose oral administration, endocrine alterations during tamoxifen therapy, 1488 phase I clinical trials, 51 estrogen receptor measurements, tritiated estradiol vs. tamoxifen advocacy groups, 1719 aziridine, 1553 aging and, 471 familial aggregation in males, 849 anorexia, treatment with megestrol acetate, optimal dose, 449 fat intake and, 321, 1035, 1491 cartoons and comics, 1132 goals for 1991, 914 cell cycling, cdc2, and (editorial}, 896 growth and lung metastases of human cancer ce!ls in nude mice, centers 1491 ambulatory, 675 Her-2/neu and INT2 proto-oncogene amplification in malignant comprehensive, 242 tumors, 1483 exemption from prospective payment system, 907 incidence M. D. Anderson Cancer Center, 671, 826 in Vaud, Switzerland, mammography and, 118! consumerism and, 1205 in Wisconsin, mammography and, 1541 control of new primary cancers after adjuvant tamoxifen therapy and cancer mortality and, 1636 radiotherapy, 1013 in Appalachia, 1791 screening and (editorial), 1522 in Southeast Asia, 326 lumpectomy with radiation vs. mastectomy, 11 symptom control studies, importance of, 963 metastases diagnosis central nervous system, tissue polypeptide antigen activity in advances during 1971-1991, 234 cerebrospinal fluid as marker of, 779 delayed, and malpractice threat, 1209 in young HIV-positive patient, 447 imaging technology, progress in (1971-1991), 1285 taxol phase II trial, 1797 education outreach program, 756 book for patients, 680 P-glycoprotein in, clinical relevance of immunohistochemical detec- disability awareness program, 538 tion of, 111 older Americans initiative, 474 p53 mutations in carcinomas, 1004 progress in (1971-1991), 1130 prevention familial studies, 82 hormones and, 1211 familial testing, 1782 tamoxifen and, 1450 fetal consequences of paternal lifestyle, 1611 progesterone receptor gene restriction fragment length polymor- genes, number of (commentary), 1061 phisms in human tumors, 1157 immunotherapy, 1789 prognosis and prognostic factors incidence evaluation guidelines (editorial), 154 by histological site, 238 nm23 gene expression, 229, 281, 1249 estimates (1991), 745 nucleoside diphosphate kinase expression, 1249 in families of children with Ewing’s tumor, 955 risk in Seattle Women’s Health Trial! participants, 1260 cohort study of fat intake and, 336 race, poverty, and, 526, 551 gonadotropin-releasing hormone agonist plus add-back sex information steroids to reduce, 1763 collaboration among services, 13 screening PDQ, use by oncologists, 469 incidence and (editorial), 1522 regionalization of service, 755 self-examination, effectiveness of (editorial), 226 late-diagnosis patients, psychodynamics of, 212 United Kingdom program, 580 mortality Vol. 83, No. 24, December 18, 1991 SUBJECT INDEX 1855 age-related trends, 811 reimbursement as determinant of choice of, 1606 among nonwhites, atlas of, 89 unconventional, 817, 1421 rates, 595, 745 Cancer: Causes, Occurrence, and Control (book review), 1341 pain Cancer Chemotherapy: Principles and Practice (book review), 208 management, 748 Cancer Experience: Nursing Diagnosis and Management (book state initiatives, 1613 review), 134 undertreatment, regulatory barriers and, 1202 Cancer Growth and Progression (book review), 208 palliative care, 326 Cancer Imaging with Radiolabeled Antibodies: Cancer Treatment and patients Research (book review), 507 activism, 528 Cancer Information Service, 1792 quality of life, 1052 Cancer Nursing: Principles and Practice (book review), 645 terminal, life insurance living benefits packages, 1442 Cancer of the Skin (book review), 1176 pediatric, 1714 Cancer Treatment (book review), 1757 prehistoric, 1289 Canines, photodynamic treatment of spontaneo‘’s cancers with chloro- prevalence, 1982-1987, 165 aluminum sulfonated phthalocyanine, 18 prevention Carboplatin “5-a-Day for Better Health” program, 1538 dose escalation with granulocyte-macrophage colony-stimulating agreements to test foods for, 1050 factor support, ovarian cancer patients, 1748 beta-carotene and, 681, 1110 hypersensitivity reactions to, 1763 cancer mortality and, 1636 with carboplatin dose escalation, ovarian cancer patients, 1748 international meeting, 391 Carcinogenesis: Progress in Clinical and Biological Research (book planning and policy considerations (commentary), 475 review), 876 progress in, 161 Carcinogenesis, rat, diet and, 1261 reading program for low-income women combined with, 1374 Carcinogenicity of dioxins (editorial), 1198 soy products and (commentary), 541 Carcinogens STOP CANCER reorganization, 1140 hemoglobin adducts, urinary mutagenicity, and metabolic phenotype vitamin C and, 396, 547 in active and passive cigarette smokers, 963 promotion of, 238 identification and action of, 161 new technologies, 6 Carcinomas, iiidline, of uncertain histologies, genetic analysis as aid tumor suppressor genes, new prospects for (review), 91 in, 314, 341 radar (traffic) guns and, 1290 Carcinomas of the Head and Neck: Cancer Treatment Research (book rates in Florida, 1704 review), 785 registry, problems in classifying invasive bladder cancer, 429 Case-control studies research canine malignant lymphoma and 2,4-dichlorophenoxyacetic acid agenda for women’s health, 1443 herbicides, 1226 clinical application emphasized by American Association for Can- nested, lung cancer in meat industry, 1337 cer Research, 819 Cells see also specific cell types clinical, poor funding rates, 838 autologous melanoma, lysis by tumor-infiltrating lymphocyctes, clinical, status in U.S., 829 clinical response and, 932 congressional budget hearings, 537 CEM-CCRF human tumor cell line, multidrug resistance assay, 206 information dissemination, 319 division cycle, cdc2, and cancer (editorial), 896 informed consent for use of patient’s cells, 368 gastric carcinoma, p53 gene abnormalities in, 938 Italian program, 1372 HL60, vacuolar H+-adenosine triphosphatase activity in multidrug new frontiers at American Society of Clinical Oncology, 821 resistance in, 1098 progress from 1971 to 1991, 84 hypoxic spin-offs for other diseases, 812, 1508 cytotoxin research (editorial), 156 symptom control studies, importance of, 963 therapeutic advantage in tumors, 178 Statistics review available, 755 informed consent for research use of, 368 surveillance, problems in delineating in situ and invasive bladder malignant lymphoma, effect of in vitro electrical stimulation on pro- cancer (editorial), 384 liferation, 116 survival multidrug resistant, magnetic-affinity cell sorting method, 565 diagnosis and treatment advances during 1971-1991 and, 234 ras-resistant and ras-sensistive, gene expression patterns in, 485 gender differences in, 579 wall skeleton, and monophosphoryl lipid A adjuvant, effect on im- survivors munogenicity of murine B16 melanoma vaccine, 1240 anniversary commemoration for, 1445 Central neryeus system childhood cancer, therapy-related germ cell mutations in, 1643 cancer incidence time trends in Connecticut, 1679 treatment metastases advances during 1971-1991, 234 of breast cancer, tissue polypeptide antigen activity in cerebro- barriers to, 468 spinal fluid as marker of, 779 clinics, unrecognized, danger of, 212 protection from systemic chemotherapy by adrenal cortico- differentiation therapy, 1209 steroids, 648 guidelines, CancerFax, 399 Cervical cancer immunology research and, 388 human papillomavirus and, 160 monoclonal antibodies (editorial), 78 in Australia, serum selenium level and, 292 pregnancy and, 900 Chemoprevention Journal of the National Cancer Institute

ebook img

Journal of the National Cancer Institute 1991: Vol 83 Index PDF

27 Pages·1991·8.4 MB·English
by  
#periodicals #sim_microfilm #pub_journal-of-the-national-cancer-institute
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Journal of the National Cancer Institute 1991: Vol 83 Index

Barrett JC, 862 Bustin M, 42 Cronise P, 757 Bartholomew R, 1470 Buzdar AU, 1797 Cunningham JE, 1629 Basse PH, 944 Bystryn JC, 1240 Curnin MGM, 849 AUTHOR Bauer HM, 997 Cuttitta F, 1470 Bauer M, 1065 Cc Cvitkovic E, 569 Beach JA, 1620 Czitrom AA, 194 INDEX Beber B, 1754 Cabanillas F, 1757 Beck WT, 1364 Cain DF, 838 D Bedi A, 876 Califano JA III, 716 Bellet RE, 648 Califano R, 1160 Dalesio O, 1024 Benedetto P, 51 Campbell H, 757 Dalton WS, 80, 105 Benedix MG, 1157 Cannon-Albright LA, 1726 Damsma O, 1408 A Benhamou E, 569 Cantor KP, 1226 Dankovic DA, 1507 Benjamin RS, 926 Caporaso NE, 64 Datta S, 1307 Benz C, 170 Carmichael J, 1748 Davidson NE, 920 Abdullah MA, 447 Berends JC, 1400 Carpenter A, 501 Davis A, 1169 Abeloff MD, 920 Berg G, 1072 Carpenter HA, 1734 Davoli E, 1160 Abildgaard N, 1391 Bergstrom R, 580 Cassady JA, 1004 DeGregorio M, 1477 Abrams JS, 1017 Berns MW, 18 Castronovo V, 29 DeJager R, 1813 Acquavella JF, 1686 Bernstein L, 1505 Cats A, 1687 Dejana E, 1321 Adami H-O, 580 Berrocal A, 449 Cavalli F, 1160 de Rooij DG, 1400 Adzick NS, 1569 Berthelsen JG, 1391 Cedermark B, 1299 Devesa SS, 369 Aebersold PM, 350, 932 Bertino JR, 24 Cederquist E, 1072 de Vries EGE, 1687 Aisner J, 1017 Beschorner WE, 133 Center MS, 1098 Dexeus FH, 285 Alberts DS, 1739 Betensky R, 1231 Cha JK, 1149 DiMagno EP, 1734 Albini A, 775 Bettelheim P, 708 Chaganti RSK, 341 Dibble SL, 1754 Alexander RB, 346 Beveridge RA, 920 Chambers AF, 485 Diener-West M, 1065 Allen PS, 1650 Beverley PCL, 609 Chambers JC, 997 D’Incalci M, 1160 Allen SL, 1017 Bhat A, 1294 Chamness GC, 1157 Dill PL, 37 Allred DC, 1477 Biggar RJ, 695 Champlin R, 576 Dionet C, 111 Aloe M, 46 Birch JM, 955 Chang M-J, 842 Divgi CR, 97 Altman N, 1754 Birrer MJ, 938 Chang Y, 640 Djuric Z, 766 Alvord WG, 1678 Bjelkengren G, 1072 Chapman JD, 1650 Dmitrovsky E, 341, 1105 Amato RJ, 285 Blair V, 955 Chapman R, 926 Dombernowsky P, 779 Ambinder R, 1176 Blaser MJ, 1734 Chase JL, 423 Donehower RC, 1778 American Medical Associa- Block G, 547 Chassagne J, 111 Dorr A, 1029, 1450 tion Council on Scientific Bloom EJ, 1500 Checkoway H, 958 Dorr RT, 1739 Affairs, 254 Bloomfield CD, 663, 1418 Chen F-M, 200 Douglass MC, 1088 Andersson M, 1013 Blot WJ, 369 Chester M, 1218 Douillard J-Y, 417 Andrulis IL, 194 Blumenthal RD, 627 Chetner MP, 1650 Dritschilo A, 480 Angus B, 281 Bobrow LG, 609 Cheung L, 1629 Drouhard T, 951 Aninipot R, 627 Boeniger M, 1686 Chiba I, 938 Duggan D, 1017 Appleton CP, 10S Boice JD, Jr, 1072 Child P, 46 Durrant LG, 866, 1245 Arencibia-Mireles O, 1085 Boldt DH, 124 Chodak GW, 329, 1346 AArrnmfaienldd JM-,P , 1566590 BBoononmeetr JAD,, 796266 CChhuy ouK C,P -H1,6 361 403 E Aronson FR, 56 Borg A, 1483 Cibas ES, 701 Arriagada R, 417 Bos! GJ, 341 Ciccone G, 362 Edelson R, 400 Arts CJ, 1347 Bosman C, 1553 Cioce V, 29 Edgerton S, 170 Aschele C, 24 Boven E, 1408, 1546, 1813 Clark GN, 124 Edwards BK, 384 Askergren J, 1299 Bowcock AM, 1085 Clark RA, 1034 Edwards J, 1294 Austin DF, 46, 849 Boyd J, 862 Clendeninn NJ, 51 Eisenhauer E, 1748 Austin EB, 1245 Boyd M, 757 Clifford CK, 299 Ellison NM, 450 Austin MA, 849 Brady JN, 1255 Coffey DS, 862 Elston RC, 65 Avis IL, 1470 Braly PS, 621 Coghlin J, 274 Enker WE, 701 Bramson J, 557 Cohen LA, 496, 1262, 1348 Ensminger WD, 1659 B Brandes LJ, 1329 Cohen SM, 880 Ensslin AS, 1564 Braunschweiger PG, 842 Collier M, 51 Epstein AL, 200 Baars JW, 1408 Brock KE, 292 Colofiore J, 1235 Ericsson U-B, 1072 Bach F, 779 Broder S, 695 Coltman CA, Jr, 1077 Erlichman C, 1169 Bachouchi M, 569 Bronzert D, 838 Comis RL, 129, 1235 Esaki Y, 1249 Baer MR, 663, 1418 Brown JM, 178 COMMIT Research Group, Eschwege F, 569 Baguley BC, 896 Brown LM, 1497 1620 Evans C, 1500 Bailey-Wilson JE, 65 Brown M, 959 Conner P, 1686 Eyre HJ, 1142, 1182 Bajorin DF, 341 Brown PD, 775 Connoliy JM, 1491 Baker LH, 926 Brownson RC, 1036 Coronado E, 1477 F Balcerzak S, 926 Bruce WR, 46 Cossman J, 980 Baldwin RW, 1245 Brunning RD, 58 Costanzi JJ, 1250 Faggiano F, 362 Bani MR, 119 Bryson P, 1748 Cowan JD, 1077 Fair WR, 294 Bannister R, 1686 Buchanin GR, 1829 Cox JD, 1065 Fajen J, 1686 Baptista J, 46 Bunni MA, 1806 Cragg G, 1294 Feillel V, 111 Baquet CR, 551 Burch PA, 294 Craig JB, 124 Feliu J, 449 Barnes S, 541 Burke TW, 1629 Cranor ML, 701 Fenoglio-Preiser C, 359, 1827 Bédron-Saura JM, 449 Burnham NL, 963 Crawford ED, 958, 1346, 1582 Ferné M, 1483 Journal of the National Cancer Institute Barrett JC, 862 Bustin M, 42 Cronise P, 757 Bartholomew R, 1470 Buzdar AU, 1797 Cunningham JE, 1629 Basse PH, 944 Bystryn JC, 1240 Curnin MGM, 849 AUTHOR Bauer HM, 997 Cuttitta F, 1470 Bauer M, 1065 Cc Cvitkovic E, 569 Beach JA, 1620 Czitrom AA, 194 INDEX Beber B, 1754 Cabanillas F, 1757 Beck WT, 1364 Cain DF, 838 D Bedi A, 876 Califano JA III, 716 Bellet RE, 648 Califano R, 1160 Dalesio O, 1024 Benedetto P, 51 Campbell H, 757 Dalton WS, 80, 105 Benedix MG, 1157 Cannon-Albright LA, 1726 Damsma O, 1408 A Benhamou E, 569 Cantor KP, 1226 Dankovic DA, 1507 Benjamin RS, 926 Caporaso NE, 64 Datta S, 1307 Benz C, 170 Carmichael J, 1748 Davidson NE, 920 Abdullah MA, 447 Berends JC, 1400 Carpenter A, 501 Davis A, 1169 Abeloff MD, 920 Berg G, 1072 Carpenter HA, 1734 Davoli E, 1160 Abildgaard N, 1391 Bergstrom R, 580 Cassady JA, 1004 DeGregorio M, 1477 Abrams JS, 1017 Berns MW, 18 Castronovo V, 29 DeJager R, 1813 Acquavella JF, 1686 Bernstein L, 1505 Cats A, 1687 Dejana E, 1321 Adami H-O, 580 Berrocal A, 449 Cavalli F, 1160 de Rooij DG, 1400 Adzick NS, 1569 Berthelsen JG, 1391 Cedermark B, 1299 Devesa SS, 369 Aebersold PM, 350, 932 Bertino JR, 24 Cederquist E, 1072 de Vries EGE, 1687 Aisner J, 1017 Beschorner WE, 133 Center MS, 1098 Dexeus FH, 285 Alberts DS, 1739 Betensky R, 1231 Cha JK, 1149 DiMagno EP, 1734 Albini A, 775 Bettelheim P, 708 Chaganti RSK, 341 Dibble SL, 1754 Alexander RB, 346 Beveridge RA, 920 Chambers AF, 485 Diener-West M, 1065 Allen PS, 1650 Beverley PCL, 609 Chambers JC, 997 D’Incalci M, 1160 Allen SL, 1017 Bhat A, 1294 Chamness GC, 1157 Dill PL, 37 Allred DC, 1477 Biggar RJ, 695 Champlin R, 576 Dionet C, 111 Aloe M, 46 Birch JM, 955 Chang M-J, 842 Divgi CR, 97 Altman N, 1754 Birrer MJ, 938 Chang Y, 640 Djuric Z, 766 Alvord WG, 1678 Bjelkengren G, 1072 Chapman JD, 1650 Dmitrovsky E, 341, 1105 Amato RJ, 285 Blair V, 955 Chapman R, 926 Dombernowsky P, 779 Ambinder R, 1176 Blaser MJ, 1734 Chase JL, 423 Donehower RC, 1778 American Medical Associa- Block G, 547 Chassagne J, 111 Dorr A, 1029, 1450 tion Council on Scientific Bloom EJ, 1500 Checkoway H, 958 Dorr RT, 1739 Affairs, 254 Bloomfield CD, 663, 1418 Chen F-M, 200 Douglass MC, 1088 Andersson M, 1013 Blot WJ, 369 Chester M, 1218 Douillard J-Y, 417 Andrulis IL, 194 Blumenthal RD, 627 Chetner MP, 1650 Dritschilo A, 480 Angus B, 281 Bobrow LG, 609 Cheung L, 1629 Drouhard T, 951 Aninipot R, 627 Boeniger M, 1686 Chiba I, 938 Duggan D, 1017 Appleton CP, 10S Boice JD, Jr, 1072 Child P, 46 Durrant LG, 866, 1245 Arencibia-Mireles O, 1085 Boldt DH, 124 Chodak GW, 329, 1346 AArrnmfaienldd JM-,P , 1566590 BBoononmeetr JAD,, 796266 CChhuy ouK C,P -H1,6 361 403 E Aronson FR, 56 Borg A, 1483 Cibas ES, 701 Arriagada R, 417 Bos! GJ, 341 Ciccone G, 362 Edelson R, 400 Arts CJ, 1347 Bosman C, 1553 Cioce V, 29 Edgerton S, 170 Aschele C, 24 Boven E, 1408, 1546, 1813 Clark GN, 124 Edwards BK, 384 Askergren J, 1299 Bowcock AM, 1085 Clark RA, 1034 Edwards J, 1294 Austin DF, 46, 849 Boyd J, 862 Clendeninn NJ, 51 Eisenhauer E, 1748 Austin EB, 1245 Boyd M, 757 Clifford CK, 299 Ellison NM, 450 Austin MA, 849 Brady JN, 1255 Coffey DS, 862 Elston RC, 65 Avis IL, 1470 Braly PS, 621 Coghlin J, 274 Enker WE, 701 Bramson J, 557 Cohen LA, 496, 1262, 1348 Ensminger WD, 1659 B Brandes LJ, 1329 Cohen SM, 880 Ensslin AS, 1564 Braunschweiger PG, 842 Collier M, 51 Epstein AL, 200 Baars JW, 1408 Brock KE, 292 Colofiore J, 1235 Ericsson U-B, 1072 Bach F, 779 Broder S, 695 Coltman CA, Jr, 1077 Erlichman C, 1169 Bachouchi M, 569 Bronzert D, 838 Comis RL, 129, 1235 Esaki Y, 1249 Baer MR, 663, 1418 Brown JM, 178 COMMIT Research Group, Eschwege F, 569 Baguley BC, 896 Brown LM, 1497 1620 Evans C, 1500 Bailey-Wilson JE, 65 Brown M, 959 Conner P, 1686 Eyre HJ, 1142, 1182 Bajorin DF, 341 Brown PD, 775 Connoliy JM, 1491 Baker LH, 926 Brownson RC, 1036 Coronado E, 1477 F Balcerzak S, 926 Bruce WR, 46 Cossman J, 980 Baldwin RW, 1245 Brunning RD, 58 Costanzi JJ, 1250 Faggiano F, 362 Bani MR, 119 Bryson P, 1748 Cowan JD, 1077 Fair WR, 294 Bannister R, 1686 Buchanin GR, 1829 Cox JD, 1065 Fajen J, 1686 Baptista J, 46 Bunni MA, 1806 Cragg G, 1294 Feillel V, 111 Baquet CR, 551 Burch PA, 294 Craig JB, 124 Feliu J, 449 Barnes S, 541 Burke TW, 1629 Cranor ML, 701 Fenoglio-Preiser C, 359, 1827 Bédron-Saura JM, 449 Burnham NL, 963 Crawford ED, 958, 1346, 1582 Ferné M, 1483 Journal of the National Cancer Institute Ferrone S, 1307 Goedert JJ, 695 Hebert JR, 872 Jensen OM, 1581 Feun LG, 51, 1250 Goldenberg DM, 78, 527 Heilbrun LK, 766 Jessen CR, 1226 Fine S, 1169 Goldenberg SK, 1386 Henderson BE, 63, 1182, 1820 Jiang FN, 1218 Finkel HE, 1421 Goldfarb RH, 944 Henderson BR, 1103 Jiang H, 1307 Fisher B, 1278 Goldgar DE, 1726 Henderson IC, 894 Jiang S, 1218 Fisher PB, 1307 Goldman E, 170 Henderson MM, 1260 Jicha DL, 350, 769 Fivenson DP, 1088 Goldson AL, 1758 Hennessy C, 281 Johansen B, 1391 Flehinger BJ, 243, 1112 Gonzdlez-Barén M, 449 Henry JA, 281 Johansson BR, 944 Fletcher JG, 1316 Gordon GB, 876, 920 Henson DE, 443, 547 Johnson CS, 842 Fletcher WS, 926 Gotay CC, 212 Herberman RB, 433, 944 Johnson ES, 1337 Fodsiad @, 1020, 1419 Gottesman MM, 565, 1307, Hersh EM, 1250 Johnson NJ, 1659 Fogler WE, 1386 1386 Hesketh PJ, 613 Johnson S, 932 Fonck Y, 111 Govindarajan S, 1820 Hickey E, 170 Johnston D, 1240 Fonk JCM, 1408 Graham GM, 1307 Hill SM, 1157 Johnston JB, 42 Ford LG, 1450 Gralla R, 97 Hines K, 932 Jones MP, 429 Forde KA, 359, 1827 Grant P, 1763 Hirano T, 1668 Jordan VC, 492, 1488 Forman AD, 1797 Gray-Goodrich M, 757 Hirayama R, 1249 Forman D, 1702 Green MR, 382 Hirokawa K, 1249 K Formby B, 1564 Greenberg RS, 849 Hirte H, 1748 Forrest AP, 581 Greene GL, 1157 Hiscott J, 557 Kabat GC, 872 Fossel ET, 1316 Greene MH, 1720 Hjalgrim H, 1391 Kaizer H, 58 Franceschi S, 139 Greenwald P, 551 Hjalmar M-L, 1299 Kamen BA, 1829 Franks CR, 1408 Grever MR, 1294 Hoekman K, 1546 Kandel R, 194 Fraumeni JF, Jr, 369 Gridley G, 292 Hoffman J, 1235 Kane SE, 565 Freedman LS, 299 Grigg W, 721 Hohn DC, 423 Kaneko Y, 1668 Freeman H, 526 Grigioni WF, 29 Hoifgdt HK, 1020 Kaplowitz LG, 139 Freireich EJ, 829 Grillo F, 1553 Hollingsworth R, 1349 Karp JE, 443, 1450 Fridman R, 769 Grobman BJ, 423 Hollingsworth RE, 91 Karsai H, 190 Friedenreich CM, 336 Grogan TM, 80 Holm L-E, 1072 Kasprzyk PG, 1470 Friedman MA, 16, 838 Groshen S, 63 Holmberg L, 580 Katzenellenbogen BS, 1434 Fritz NF, 1488 Gruys E, 1386 Holmes EC, 228 Kavanagh JJ, 1629 Frustaci S, 1160 Grzegorzewski K, 1149 Holmes FA, 1797 Kefford RF, 1103 Frye DK, 1797 Guarini L, 1307 Hong WK, 1110, 1111 Keller JB, 1231 Fujisue M, 1743 Gumbart C, 1077 Hoover RN, 1497 Keller JR, 1672 Fujita J, 1668 Gumbrell L, 1160 Hopfner M, 708 Kendall ME, 496, 1262, 1348 Fukatsu A, 1668 Gurgin V, 46 Horm JW, 551, 695 Kennedy KA, 632 Fukumoto M 1668 Gurpide E, 40S Horn T, 1176 Kennedy MJ, 920 Fukuoka M, 855, 1164, 1743 Horowitz ME, 1460 Kern F, 716 Fukuyama H, 1668 H Hortobagyi GN, 1797 Kessel MAP, 1813 Fuqua SAW, 1157 Horwitz JP, 1508 Key C, 849 Furmanski P, 842 Haas OA, 708 Horwitz SB, 288 Keyes SR, 632 Furuse K, 855 Hainesworth JD, 1757 Hose C, 757 Khokha R, 485 Haisma HJ, 1813 Hossan E, 285 Kiang DT, 462 G Hakulinen T, 579 Howard BH, 565 Kibbey MC, 769 Hall EJ, 156 Howe GR, 336, 1035, 1505 Kim J-H, 938 Gail MH, 695 Hall P, 1072 Howell SB, 621 Kim J-P, 938 Gandara DR, 613 Hallahan DE, 480 Hruban RH, 1024 Kim S, 621 Gann PH, 274 Hallquist A, 1072 Hsieh C, 1324 Kimmel M, 701 Gannon JE, 116 Halperin W, 501 Hsu G, 1182 Kimura N, 1249 Garbisa S, 29 Halpert RD, 1034 Hu XF, 206 Kirmani S, 621 Garbowski GC, 359, 1827 Hammond SK, 274 Hudes GR, 1235 Kjgnniksen I, 1020 Garewal H, 1111 Hande KR, 1523 Hui KKS, 1316 Kleibeuker JH, 1687 Garofalo A, 119 Handley FG, 1294 Hutchins LF, 1077 Klein MK, 18 Gause BL, 1149 Hankey BF, 384 Hutchinson M, 557 Kleinman HK, 769, 1509 Gazdar AF, 938 Hanlon J, 51 Hyatt C, 932 Knol JA, 1659 Gazzaniga JM, 429 Hansen EB, 200 Knutsen CA, 1659 Geissler K, 708 Hansen SO, 1391 Koeller J, 124 Geleziunas R, 557 Harada K, 186 Kolonel L, 849 Gerber G, 1346 Harman G, 124 Iga H, 186 Komschlies K, 1386 Gerber GS, 329 Harper GR, 447 Ikegami H, 855 Kondo Y, 186 Gerhardsson de Verdier M, Harris M, 955 Isaacs JT, 346 Konrad M, 129 1505 Harris WF, 1294 Isacson P, 849 Koong A, 178 Getzenberg RH, 862 Harrison MR, 1569 Isonishi S, 621 Kopecky KJ, 1250 Giavazzi R, 119 Harrison SD, Jr, 1509 Kopp WC, 1678 Gibbs T, 551 Hartley AL, 955 J Kopper L, 1174 Giffen CA, 1620 Haskell CM, 314 Kopriva D, 557 Gilpin E, 1009 Haut M, 712 Jacobsen SEW, 1672 Korcak L, 932 Giovino G, 1009 Havelec L, 708 Jain M, 336 Koski B, 1748 Glas U, 1299 Havlin KA, 124 Jain RK, 433 Koutsky L, 978 Glasgow RE, 1620 Hawkins MM, 1643 James WH, 1420 Kovach JS, 2, 791, 1004 Glass A, 368 Hay K, 46 Jane JA, 880 Kovacs TOG, 1470 Glazer E, 46 Hayes HM, 1226, 1497 Javadpour N, 1497 Kramer BS, 1450, 1636 Glazer RI, 42 Haywood L, 627 Jazmaji V, 46 Kreis W, 725 Goates J, 640 Heald P, 400 Jenkins J, 1412 Krigel RL, 129 Vol. 83, No. 24, December 18, 1991 AUTHOR INDEX 1849 Kris M, 97 Looijenga LHJ, 1400 Miaskowski C, 1754 O Krull EA, 1088 Loomis M, 18 Michelson S, 1574 Kudoh S, 1164, 1743 Loprinzi CL, 450, 963 Mick R, 1560 O’Clock GD, Jr, 116 Kufe DW, 480 Loschiavo SR, 212 Miles VA, 1149 O’Connell G, 1748 Kuhn JG, 124 Lote K, 1092 Miller AB, 336, 1111 O’Connell KJ, 1497 Kurashima C, 1249 Lotze M, 932 Miller LL, 1412 O’Dwyer PJ, 1235 Kusunoki Y, 1164, 1743 Lubin MB, 1831, 1832 Miller RW, 1341 Offerhaus GJ, 1024 Kuwano H, 1395 Luboinski B, 569 Miller TP, 105 Olden K, 1149 Kwiatkowski F, 111 Ludwig H, 708 Mills PK, 1037 O’Malley BW, 1157 Kyprianou N, 346 Lum BL, 682 Mills S, 1009 Olsen JH, 1581 Lundell G, 1072 Minford J, 1017 Olsson H, 1483 L Lung Cancer Study Group, Minna JD, 938 Oosterhuis JW, 1400 266 Mishima Y, 1249 Ordéfiez A, 449 Lababidi MK, 492 Lynch CF, 429 Moench T, 576 Oredipe OA, 1149 LaBella FS, 1329 Lynch HT, 951 Moller H, 1581 Ortaldo JR, 646 Laberge F, 1169 Lynch J, 951 Monks A, 757 Osborne CK, 1077, 1477 Lacombe-Terrier M-J, 417 Lynch PM, 951, 1688 Mooi WJ, 1024 Osoba D, 190, 1169 La Creta FP, 1235 Lyte M, 116 Moore D III, 170 Msterlind A, 1391 Lad&nyi A, 1174 Mori M, 1395 Ozer H, 1413 Laerum OD, 1092 M Morino H, 1743 Ozols RF, 1235 Lamers W, 1500 Morita M, 1395 Lamki L, 1629 Malapetsa A, 557 Morris DL, 866 P Landry J, 170 Manos MM, 997 Morris JS, 292 Langan-Fahey S, 492, 1488 Marcus S, 1009 Morris L, Jr, 722 Padavic-Shaller KA, 129 Lange PH, 1199 Markowitz S, 501 Morrison AS, 226 Padmanabhan R, 565 Langley J, 757 Markowitz SD, 712 Morton JF, 138 Paffenbarger RS, Jr, 1324 Lanspa S, 951 Marquardt D, 1098 Mosley K, 105 Paganini-Hill A, 1182 Lantz PM, 1540 Marsden HB, 955 Motzer RJ, 341 Page DL, 648 Laplanche A, 417 Martin DS, 1235 Moulton TA, 1307 Page R, 190 Larson S, 1602 Martin GR, 769 Mouridsen HT, 1013 Paik S, 716 Larson SM, 97 Martin M, 417 Mulé JJ, 350 Pajak TF, 1065 Larsson L-G, 1072 Martin-Padura I, 1321 Mulshine JL, 1470 Palmer C, 951 Latreille J, 1169 Martini F, 511 Mulvihill SJ, 423 Palmer JR, 355, 1183 Laurensse E, 437 Martino S, 766, 1077 Munck J-N, 569 Panasci L, 557 Lauri D, 1321 Martens HJM, 1813 Munck-Hansen J, 1391 Pannacciulli I, 511 La Vecchia C, 139, 1181 Mason-Liddil N, 1739 Muquardt C, 1553 Park J-G, 938 Lawrence TS, 507 Masuda N, 1164, 1743 Murray D, 1028 Parkin JD, 206 Le Boit PE, 56 Matsuda H, 1395 Murray JL, 1629 Parnes HL, 1017 Le Chevalier TL, 417 Matsui K, 1164, 1743 Murray N, 190 Parsa NZ, 341 Lechner K, 708 Mattsson A, 1299 Murray TI, 1827 Parsonnet J, 640 Leclercq G, 1553 May FEB, 281 Pastan I, 565, 1386 Ledermann JA, 609 Mayall B, 170 Pater J, 1169 Lee H-D, 938 Mayer RJ, 806 N Paul M, 274 Lee I-M, 1324 Mayo J, 757 Paull K, 757 Lee WC, 359 Mazurka J, 1748 Nadal JC, 437 Pearson FC, 37 Lee W-H, 91, 637, 1349 McClay EF, 621 Nagourney RA, 1418 Pearson JW, 1386 Lennard TWJ, 281 McClure S, 1077 Nagy P, 1174 Pechacek TF, 1142 Levi F, 1181 McCoy CB, 1754 Nakagawa K, 1743 Pennock GD, 105 Levin L, 1748 McCurnin DM, 1226 Nakayama H, 1668 Perbeck L, 1299 Levine AM, 662 McDonagh J, 1316 Nannmark U, 944 Percy CL, 384 Levine M, 547 McGovern RM, 1004 Naquin M, 1009 Perez-Perez GI, 1734 Levy JG, 1218 McGuire DB, 134 Natale A, 627 Peters GJ, 437 Levy RL, 212 McGuire WL, 154, 1157 Natale RB, 1250 Peterson J, 1413 Lewis BJ, 423 McKeown-Eyssen GE, 46 Nayfield SG, 1450 Pfister DG, 341 Ley C, 997 McMahon BJ, 916 Needham L, 1321 Phillips JG, 1739 Li CC, 46 McPhee MS, 1650 Negoro S, 1164, 1743 Piantadosi S, 266 Li GF, 46 McQuillan A, 557 Neidhart J, 1077 Piccart MJ, 1553 Li S, 637 McSharry JJ, 447 Neugut AI, 359, 1827 Piekarski J-D, 569 Liao SH, 51 McTiernan A, 849 Neumann RD, 507 Pienta KJ, 862 Lidberg M, 1072 McWhorter WP, 1182 Neun JL, 645 Piepkorn MW, 1726 Lindberg S, 1072 Mee D, 46 Newcomb PA, 260, 1540 Pierce JP, 1009 Linkesch W, 708 Meeker BE, 1650 Newton LK, 1797 Pihl A, 1020 Liotta LA, 29, 775 Meissonnier F, 111 Neyndorff H, 1218 Pike MC, 63, 1505, 1763 Lippman ME, 716 Melamed MR, 701 Nicolin A, 24 Pinedo HM, 437, 1408, 1546, Lippman SM, 1110, 1111 Melchiori A, 775 Nielsen BB, 1754 1813 Little C, 190 Melder RJ, 433 Niitani H, 1164 Pirker R, 708 Liu DJ, 1218 Mellemgaard A, 1581 Nijman HW, 1408 Pirotte P, 1553 Lofters W, 1169 Mendelsohn J, 97 Nisen PD, 1085 Plagne R, 111 Logothetis CJ, 285, 786 Merchant B, 97 Nishioka M, 1743 Plaizier ABD, 1813 Lokich J, 1585 Meschter CL, 496, 1491 Nishiwaki Y, 855 Planner RS, 1763 London §S, 1505 Messina M, 541 Nomura AMY, 1403 Platz CE, 429 London T, 916 Metch B, 926 Nordlund JJ, 1088 Plaxe SC, 621 Longaker MT, 1569 Meyer LJ, 1726 Normolle DP, 1659 Plezia P, 105 Longo DL, 1386, 1672, 1678 Meyskens F, Jr, 1111 Nowell PC, 1061 Plezia PM, 1739 Journal of the National Cancer Institu.— Pluda JM, 695 Ryan J, 926 Smart CR, 1636 Tellez-Bernal E, 569 Polednak AP, 1679 Smith MA, 1460 Tennvall J, 1072 Pomaranski M, 1088 S Smith TJ, 139 Terrio P, 1659 Pontén J, 580 Smith JW II, 1678 Testa JE, 740 Portlock CS, 1106 Smithgall TE, 42 Theriault RL, 1797 Saijo N, 855 Pottern LM, 1497 Snader K, 1294 Theve T, 1299 Sakmar E, 1659 Pratt CB, 880 Sobel ME, 29 Thijssen JHH, 1347 Salmon SE, 105 Prieskorn D, 1659 Sobrero A, 24 Thomas DB, 849 Samaniego F, 341 Priest DG, 1806 Soletormos G, 779 Thompson L, 1629 Samson MK, 1250 Pritikin J, 640 Somell A, 1299 Thompson M, 1488 Sanders M, 932 Sommer SS, 1004 Thompson RS, 1260 Q Santi L, 775 Soderlind K, 1650 Thompson WD, 849 Saracci R, 1362 Sondik EJ, 695, 1829 Thor A, 170 Quigley JP, 740 Sartor O, 877 Souhami RL, 609 Timmins D, 1763 Quoix E, 4174 Sartorelli AC, 632 Sparén P, 580 Tong MJ, 1820 Sasaki A, 433 Speyer JL, 1682 Topalian S, 932 Satariano W, 849 R Spicer DV, 63, 1763 Tormey DC, 1488 Sato M, 186 Sridhar KS, 51 Torok N, 1174 Savaraj N, 51 Stadtmauer E, 1254 Torti FM, 682 Raber MN, 1797 Sawai S, 1249 Stagg RJ, 423 Travis WD, 350 Rabkin CS, 695 Scanziani E, 119 Stalsberg H, 849 Treat MR, 359, 1827 Ranstam J, 1483 Schepartz SA, 1294 Staunton MR, 56 Treston AM, 1470 Rasmussen LH, 1391 Scheper RJ, 1408 Steakley C, 645 Trimble L, 1650 Ratain MJ, 1560 Scherrer R, 708 Steeg PS, 712 Tsuruo T, 565, 1386 Rayner AA, 423 Schiffman MH, 997 Steenland K, 1380 Tuck AB, 485 Reading BA, 766 Schlegel R, 980 Stefanek M, 1254 Tujimoto H, 186 Real FX, 97 Schmitz JC, 1806 Steinfeld J, 1126 Recondo G, 569 Schmookler BM, 29 Reddy PG, 1307 Schneider RJ, 721 Steis RG, 1678 U Stemhagen A, 849 Redmond C, 1278 Scholes D, 260 Stemmermann GN, 1403 Reif AE, 64 Schottenfeld D, 243, 1112 Ueland PM, 1092 Stephens RL, 1077 Reingold A, $97 Schutte SE, 1400 Unger M, 97 Stern M, 1569 Remick SC, 447 Schutz M, 958 Ungerleider RS, 16, 1460 Stern R, 1569 Remington PL, 1540 Schwartz L, 170 Urba WJ, 1678 Stetler-Stevenson WG, 775 Reuter VE, 341 Schwartz PE, 637 Usui N, 1386 Stetson PL, 1659 Rheins LA, 1088 Schwartz R, 124 Utsuyama M, 1249 Stobbe CC, 1650 Richardson RC, 1226 Schweighart S, 97 Uzych L, 368, 1589 Stolinsky DC, 1589 Richman §, 51 Schweitzer J, 1294 Stolley PD, 355 Ries LA, 384 Scudiero D, 757 Storer BE, 260 v Riggs CW, 1386 Scully MC, 56 Storm HH, 1013 Rinehart JJ, 1250 Seifter EJ, 208, 1831 4 Streicher HZ, 1340 Vaigro-Wolff A, 757 Ringborg U, 1299 Seligman PA, 1582 Streicher R, 1686 Valent P, 708 Ringel I, 288 Sella A, 285 Struck RF, 1739 Valentino L, 58 Roberts D, 501, 1686 Sellers TA, 65 Stuart RK, 1806 Valeriote FA, 766 Roberts WG, 18 Sessa C, 1160 Stutzman RE, 1497 van den Berg H, 1347 Robins RA, 1245 Severson RK, 1028 Suemasu K, 855 van Dissel-Emiliani FM, 1400 Rockwell S, 632 Shackney SE, 1105 Sugimachi K, 1395 van Groeningen CJ, 437, Rodenhuis S, 1024 Shah A, 190 Sukhatme V, 480 1408, 1546 Rodriguez E, 341 Shambaugh E, 384 Sulkes A, 1160 Van Nevel P, 1421 Roe DJ, 1739 Shanken LJ, 1629 Svardal AM, 1092 Vandersteen D, 640 Roeske WR, 105 Shapiro S, 355, 1183, 1522 Swanson C, 1340 van Muijen M, 1813 Roh JK, 938 Sharkey RM, 627 Swanson SK, 1004 Vaughan CB, 1077 Roh M, 423 Sherman ML, 480 Sweeney TM, 769 Veenstra S, 1553 Rolland-Portal I, 1181 Shimada N, 1249 Venock AP, 423 Roos JC, 1813 Shimoyama M, 855 Rose DP, 496, 1491 Shmookler BM, 29 T Vermorken JB, 1408, 1546 Verrelle P, 111 Rosenberg L, 355, 1183 Shoemaker R, 757 Vilcek J, 807 Rosenberg SA, 350, 932 Shopland DR, 1142 Taghizadeh K, 274 Vineis P, 362 Rosenblatt KA, 849 Shoupe D, 1763 Taguchi T, 1164 Vistica D, 757 Rosenblum MG, 1629 Sibley RK, 640 Tait N, 1017 Vogelstein B, 1004 Rosenthal JF, 1497 Sidransky D, 785 Takada M, 1164, 1743 Voigt LF, 260 Ross JS, 447 Sigurdsson H, 1483 Takagi Y, 1249 Vokes EE, 785 Ross RK, 1182 Sikic BI, 738 Takahashi T, 938 Volker K, 1386 Rosso R, 24 Silbergeld EK, 1198 Takenawa J, 1668 Von Hoff DD, 124 Rothschild H, 65 Silva EG, 1629 Takifuji N, 1164, 1743 Rotstein S, 1299 Simon R, 1261, 1460 Talley NJ, 1734 Rowinsky EK, 1778 Sizer B, 580 Tamura T, 855 Ww Rowley SD, 920 Skehan P, 757 Tannenbaum SR, 274, 1507 Royce LS, 769 Skipper PL, 274 Tarayre M, 417 Waber PG, 1085 Ruckdeschel JC, 447 Skolnick MH, 1726 Tarone RE, 1226, 1497 Wagstaff J, 1408, 1546 Rudolph AA, 129 Skoog L, 1299 Tashiro CJ, 997 Wainberg MA, 557 Ruffie P, 417 Slamon DJ, 229 Taylor CR, 200 Walczak J, 1235 Ruscetti FW, 1672 Slate D, 1574 Te V-C, 1181 Wall DM, 206 Rusthoven J, 1169, 1748 Slebos RJC, 1024 Teare MD, 955 Wallner J, 708 Rutqvist LE, 1299 Smaaland R, 1092 Tedeschi M, 362 Walsh JH, 1470 Vol. 83, No. 24, December 18, 1991 AUTHOR INDEX Walters RS, 1797 Weldy S, 18 Wilson JD, 1686 Yeh SD, 97 Waiz N, 1650 Wellstein A, 716 Willson JKV, 712 Yeung KS, 46 Ward EM, 501, 1380, 1507, Welsch CW, 300, 1262 Wilson K, 1169 Yoshida H, 186 1686 Welt S, 97 Wilson SM, 485 Yoshida O, 1668 Wargovich MJ, 951, 1688 Wencyk PM, 866 Wiltrout RH, 1386 Young BE, 260 Warr D, 1169 West D, 849 Winawer SJ, 243, 1034, 1112 Young JD, 129 Warren RS, 423 Westley BR, 281 Winograd B, 1160 Yu MC, 1820 Warrington RC, 1329 Weston A, 1682 Wohlganger J, 1585 Yura Y, 186 Warshauer ME, 355 Wharton JT, 1629 Wolchok JD, 807 Watson AL, 866 White E, 1260 Wold LE, 1004 Watson SA, 866 White SL, 1149 Wu JM, 963 Z Waye JD, 359, 1827 Whitehead RP, 1250 Wu RS, 838 Weadock KS, 627 Whiteside TL, 433 Wunder JS, 194 Zain M, 769 Weaver A, 1734 Whittemore AS, 1231 Wynder EL, 475 Zalcberg JR, 206 Weber LA, 170 Wibault P, 569 Zalupski M, 926 Weerasiri T, 1763 Wicklund H, 1072 Zang E, 496, 1262 Weichselbaum RR, 480 Wiebe V, 1477 Y Zang F, 1348 Weiden PL, 266 Wiebelt H, 579 Zauber AG, 355 Wein S, 1348 Wiklund K, 1072 Yanagawa T, 186 Zeiger E, 1177 Weiner LM, 129 Wilding G, 365 Yang J, 932 Zhu SL, 46 Weisenthal LM, 37, 790 Wilking N, 1299 Yang Z, 1659 Zinsmeister AR, 1734 Weiss GR, 124, 926 Willian A, 1169 Yang-Feng TL, 637 Zone JJ, 1726 Weiss NS, 260 Willett WC, 292, 1035 Yannelli JR, 769 Zucchetti M, 1160 Weitman SD, 1829 Willingham MC, 565 Yarchoan R, 695 Zugmaier G, 716 A Public Service of the Forest Service, ONLY YOU CAN PREVENT FOREST FIRES. © a USDA, and your State Foresters. Journal of the National Cancer Institute progress in development of (1971-1991), 1370 screen, high-flux, using diverse panel of cultured human tumor SUBJECT cell lines, feasibility of, 757 effects of food components, 163 Antiemetic agents, serotonin antagonists as (review), 613 INDEX Antiestrogen resistance, breast cancer cell mechanism for undermin- ing effectiveness of endocrine therapy (editorial), 1434 Antifolates, rapid development of resistance in vitro, clinical implica- tion, 24 Antigens lung cancer, results of second international workshop (commentary), 609 A Thy-1 and T-cell receptor expression in mycosis fungoides and benign inflammatory dermatoses, 1088 Acquired immunodeficiency disease see also Human immuno- tissue polypeptide, activity in cerebrospinal fluid, marker of breast deficiency virus cancer metastases, 779 cimetidine treatment of Kaposi’s sarcoma in, pilot study, 139 Anti-inflammatory drugs, nonsteroidal, and incidence of large-bowel non-Hodgkin’s lymphoma incidence, 232, 695 cancer, 355 recommendations of National Commission, 1449 Antineoplastic drugs, combined with intracellular histamine an- Activism, cancer patient, 528 tagonists, therapeutic index, 1329 Adenocarcinoma Antitumor activity, biological response modifiers (editorial), 2 colon Aphidicolin glycinate, phase I and clinical pharmacological evalua- cell resistance to antifolates in vitro, 24 tion of, 1160 intestinal- and diffuse-type gastric, Helicobacter pylori infection Applications of Diffusion Theory to Cancer Care in the United States in, 640 (book review), 959 laminin receptor expression in, 29 Asbestos, and colorectal adenomatous polyps and cancer, 1827 gastric, Helicobacter pylori infections and, 640, 1702, 1734 Ascorbic acid lung (human), K-ras oncogene activation and smoking, relationship protection against cancer, 396 in, 1024 biologic functions and relation to cancer (commentary), 547 metastatic, cyclophosphamide doxorubicin, fluorouracil, and Aspirin leucovorin for, 1017 beta-carotene and vitamin E cancer prevention study for women, Adolescents, tobacco use by high school students, 1615 1531 Adrenal corticosteroids, protection of central nervous system metas- large-bowel cancer incidence in California retirement community, tases from systemic chemotherapy by, 648 1182 Advances in Cancer Control: Screening and Prevention Research— prevention trials for women smokers, 681 Progress in Clinical and Biological Research (book review), 443 Atlas of Bone Marrow Pathology (book review), 58 Age and cancer mortality, 811 B and pap smear rates, 989 Aging, and cancer, 471 Agreements, to test foods for cancer prevention, 1050 Ballplayers, smokeless tobacco cessation project for, 1215 AIDS see Acquired immunodeficiency disease Basic Mechanisms: Progress in Clinical and Biological Research AIDS Vaccine Research and Clinical Trials (book review), 1340 (book review), 876 Alpha-tocopherol, prevention trials for women smokers, 681 Beryllium American Association for Cancer Research, clinical application of and lung cancer (editorial), 1362 research findings emphasized at, 819 disease, lung cancer among patients with, cohort mortality study, American Association for the Advancement of Science, aging and 1380 cancer discussions, 471 Beta-carotene American Cancer Society, funding for grants, 90 aspirin and vitamin E cancer prevention study for women, 1531 American Society of Clinical Oncology, new frontiers in cancer re- prevention of cancer, 1110 search, 821 prevention trials for women smokers, 681 4-Aminobipheny! hemoglobin adducts, in fetuses exposed to tobacco Biological diversity, and drug development (commentary), 1294 smoke in utero, 274 Biological response modifiers Aniline, bladder cancer in workers exposed to, 501, 1507, 1686 effective use of (editorial), 2 Animal research immunopotentiating, effect of prior cancer chemotherapy on human chimpanzees and libel suit, 1589 tumor-specific cytotoxicity in vitro in response to, 37 exotic species in, 1438 prior chemotherapy and activity of, 790 regulations, 1436 progress in research (1971-1991), 530 Anorexia, cancer-related, treatment with megestrol acetate, optimal Biology of Hematopoiesis: Progress in Clinical and Biological Re- dose, 449 search (book review), 876 Antibodies see Monoclonal antibodies Biomarkers, advances in chemoprevention research, 1369 Anticancer Biomedical research drug Institute of Medicine recommendations to NIH, 4 discovery (editorial), 738 issues addressed at congressional reauthorization hearing, 608 monitoring during therapy (editorial), 1523 U.S. leadership in, 393 Vol. 83, No. 24, December 18, 1991 SUBJECT INDEX 1853 Biopsies, breast, defensive, 1207 Diet for a Poisoned Planet: How to Choose Safe Foods for You and Biotechnology, progress in, 6, 1608 Your Family, 721 Bisantrene, with doxorubicin and mitoxantrone in advanced breast Diet, Life-Style, and Mortality in China: A Study of the Charac- cancer, 1077 teristics of 65 Chinese Counties, 1340 Bladder cancer Effects of Therapy on Biology and Kinetics of the Residual Tumor, advanced transitional cell carcinoma, gallium nitrate treatment, 1582 Part A: Pre-Clinical Aspects—Progress in Clinical and Biologi- in situ distinguished from invasive, surveillance problems (editorial), cal Research, 1105 384 Effects of Therapy on Biology and Kinetics of the Residual Tumor, invasive, registry problems in classifying, 429 Part B: Clinical Aspects—Progress in Clinical and Biological Re- piritrexim capsules using prolonged, low-dose oral administration, search, 1105 phase I clinical trials, 51 Environmental Genotoxicity, Risk, and Modulation: Progress in superficial, adjuvant intravesicular pharmacotherapy for (review), Clinical and Biological Research, 876 682 Extremely Low Frequency Electromagnetic Fields: The Question of workers exposed to ortho-toluidine and aniline, 501, 1507, 1686 Cancer, 1028 Blue Cross/Blue Shield, autologous bone marrow transplant coverage, Familial Cancer, 1830 Flow Cytometry and Sorting, Second Edition, 133 12 Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treat- Bone marrow ment, 576 glutathione in, and circadian stage relation to DNA synthesis, 1092 Hematopoietic Growth Factors in Clinical Applications, 1412 proliferation, protective effects of swainsonine during cytotoxic Hereditary Cancer and Preventive Surgery, 1829 chemotherapy, 1149 Hodgkin’ sD isease: The Consequences of Survival, 1106 registries, growth of, and patient survival, 988 Human Retroviruses: UCLA Symposia in Molecular and Cellular transplants Biology, 1255 autologous, for breast cancer treatment, 12, 894, 920 Introduction to Radiobiology, 1028 cancer treatment with, 388 Leukaemia Diagnosis: A Guide to the FAB Classification, 443 insurance coverage of trials, 1136 Malignant Lymphoma: Biology, Natural History, and Treatment, quality of life evaluated in trials, 1137 1757 Bone Marrow Transplantation (book review), 1500 Management of Pain, Volumes I and II, 208 Bone Marrow Transplantation in Children (book review), 58 Manual of Clinical Oncology, 722 Bone sarcomas, alterations in retinoblastoma gene and tumor grade, Metabolism, Testing Methods, and Chromosomes: Progress in Clini- 194 cal and Biological Research, 876 Bone Tumors: Clinical, Radiologic, and Pathologic Correlations Molecular Genetics in Cancer Diagnosis, 877 (book review), 208 Mutagens and Carcinogens in the Diet, 1177 Book reviews Natural Killer Cells: Biology and Clinical Application, 646 Advances in Cancer Control: Screening and Prevention Research— Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Progress Progress in Clinical and Biological Research, 443 in Clinical and Biological Research, 786 AIDS Vaccine Research and Clinical Trials, 1340 Neoplastic Diseases of the Blood, 1829 Applications of Diffusion Theory to Cancer Care in the United Neuro-Oncology: Primary Malignant Brain Tumors, 294 States, 959 New Aspects in the Diagnosis and Treatment of Hodgkin’ s Disease: Atlas of Bone Marrow Pathology, 58 Recent Results in Cancer Research, 1176 Basic Mechanisms: Progress in Clinical and Biological Research, New Strategies in Bone Marrow Transplantation, 1254 876 Non-Hodgkin’ sL ymphomas, 208 Biology of Hematopoiesis: Progress in Clinical and Biological Re- Occupational Cancer Epidemiology, Recent Results in Cancer Re- search, 876 search, 958 Bone Marrow Transplantation, 1500 On Death Without Dignity: The Human Impact of Technological Bone Marrow Transplantation in Children, 58 Dying, 1500 Bone Tumors: Clinical, Radiologic, and Pathologic Correlations, Oncogenes and the Molecular Origins of Cancer, 785 208 Oncology Nursing Advances, Treatments, and Trends Into the 21st Cancer: Causes, Occurrence, and Control, 1341 Century, 1412 Cancer Chemotherapy: Principles and Practice, 208 Prostate Cancer and Testicular Cancer: Progress in Clinical and Cancer Experience: Nursing Diagnosis and Management, 134 Biological Research, 365 Cancer Growth and Progression, 208 Race Is Run: One Step at a Time, 1254 Cancer Imaging with Radiolabeled Antibodies: Cancer Treatment Radiation Oncology: Radiobiological and Physiological Perspec- and Research, 507 tives, 507 Cancer Nursing: Principles and Practice, 645 Regional Antineoplastic Drug Delivery in the Management of Cancer of the Skin, 1176 Malignant Disease, 1682 Cancer Treatment, 1757 Retrovirus Biology and Human Disease, 576 Carcinogenesis: Progress in Clinical and Biological Research, 876 Role of High Energy Electrons in the Treatment of Cancer, 1758 Carcinomas of the Head and Neck: Cancer Treatment Research, Somatic and Heritable Mutation, Adduction, and Epidemiology: 785 Progress in Clinical and Biological Research, 876 Chronic Myelogenous Leukemia: Molecular Approaches to Re- Temporal Control of Drug Delivery, 1585 search and Therapy, 1413 Treatment of Early Breast Cancer: Worldwide Evidence, 1985-1990, Complex Mixtures and Cancer Risk, 1682 1029 Current Genitourinary Cancer Surgery, 294 Treatment of Prostatic Cancer: Facts and Controversies—Progress Detection and Treatment of Early Breast Cancer, 721 in Clinical and Biological Research, 365 Journal of the National Cancer Institute Triumph: Getting Back to Normal When You Have Cancer, 1585 segregation analysis of, histopathologic data, 648 Uro-oncology: Current Status and Future Trends, 958 stress response protein determination in primary carcinomas, clini- Brain cal, histologic, and prognostic correlations, 170 cancer incidence time trends in Connecticut, 1679 studies, combined analysis of, 1505 mapping, space imaging technology applied to, 986 surgery trends, 1607 Breast see Mammary for animal studies taxol efficacy, 11 biopsies, defensive, 1207 treatment, very-high-dose chemotherapy with autologous bone mar- imaging, 1444 row transplantation, 894, 920 Breast cancer advanced breast self-examination and, 260 C doxorubicin, bisantrene, and mitoxantrone in, 1077 recombinant human granulocyte macrophage colony-stimulating California factor, and chemotherapy-induced myelosuppression, 1546 aspirin use and large-bowel cancer incidence in retirement com- antiestrogen resistance as cell mechanism for undermining effective- munity, 1182 ness of endocrine therapy (editorial), 1434 non-Asians of Los Angeles County, non-viral risk factors for autologous bone marrow transplant treatment, 12 hepatocellular carcinoma in, 1820 awareness month, 1449, 1534 Camptothecin, CPT-11 derivative for treatment of advanced non— chemoprevention, readiness for (editorial), 462 small-cell lung cancer, 1164 coalition, 756 Cancer see also specific sites, histological sites, Tumor congressional attention to, 996 advanced malignancies contralateral, tamoxifen as preventive agent, 1278, 1299 piritrexim capsules using prolonged, low-dose oral administration, endocrine alterations during tamoxifen therapy, 1488 phase I clinical trials, 51 estrogen receptor measurements, tritiated estradiol vs. tamoxifen advocacy groups, 1719 aziridine, 1553 aging and, 471 familial aggregation in males, 849 anorexia, treatment with megestrol acetate, optimal dose, 449 fat intake and, 321, 1035, 1491 cartoons and comics, 1132 goals for 1991, 914 cell cycling, cdc2, and (editorial}, 896 growth and lung metastases of human cancer ce!ls in nude mice, centers 1491 ambulatory, 675 Her-2/neu and INT2 proto-oncogene amplification in malignant comprehensive, 242 tumors, 1483 exemption from prospective payment system, 907 incidence M. D. Anderson Cancer Center, 671, 826 in Vaud, Switzerland, mammography and, 118! consumerism and, 1205 in Wisconsin, mammography and, 1541 control of new primary cancers after adjuvant tamoxifen therapy and cancer mortality and, 1636 radiotherapy, 1013 in Appalachia, 1791 screening and (editorial), 1522 in Southeast Asia, 326 lumpectomy with radiation vs. mastectomy, 11 symptom control studies, importance of, 963 metastases diagnosis central nervous system, tissue polypeptide antigen activity in advances during 1971-1991, 234 cerebrospinal fluid as marker of, 779 delayed, and malpractice threat, 1209 in young HIV-positive patient, 447 imaging technology, progress in (1971-1991), 1285 taxol phase II trial, 1797 education outreach program, 756 book for patients, 680 P-glycoprotein in, clinical relevance of immunohistochemical detec- disability awareness program, 538 tion of, 111 older Americans initiative, 474 p53 mutations in carcinomas, 1004 progress in (1971-1991), 1130 prevention familial studies, 82 hormones and, 1211 familial testing, 1782 tamoxifen and, 1450 fetal consequences of paternal lifestyle, 1611 progesterone receptor gene restriction fragment length polymor- genes, number of (commentary), 1061 phisms in human tumors, 1157 immunotherapy, 1789 prognosis and prognostic factors incidence evaluation guidelines (editorial), 154 by histological site, 238 nm23 gene expression, 229, 281, 1249 estimates (1991), 745 nucleoside diphosphate kinase expression, 1249 in families of children with Ewing’s tumor, 955 risk in Seattle Women’s Health Trial! participants, 1260 cohort study of fat intake and, 336 race, poverty, and, 526, 551 gonadotropin-releasing hormone agonist plus add-back sex information steroids to reduce, 1763 collaboration among services, 13 screening PDQ, use by oncologists, 469 incidence and (editorial), 1522 regionalization of service, 755 self-examination, effectiveness of (editorial), 226 late-diagnosis patients, psychodynamics of, 212 United Kingdom program, 580 mortality Vol. 83, No. 24, December 18, 1991 SUBJECT INDEX 1855 age-related trends, 811 reimbursement as determinant of choice of, 1606 among nonwhites, atlas of, 89 unconventional, 817, 1421 rates, 595, 745 Cancer: Causes, Occurrence, and Control (book review), 1341 pain Cancer Chemotherapy: Principles and Practice (book review), 208 management, 748 Cancer Experience: Nursing Diagnosis and Management (book state initiatives, 1613 review), 134 undertreatment, regulatory barriers and, 1202 Cancer Growth and Progression (book review), 208 palliative care, 326 Cancer Imaging with Radiolabeled Antibodies: Cancer Treatment and patients Research (book review), 507 activism, 528 Cancer Information Service, 1792 quality of life, 1052 Cancer Nursing: Principles and Practice (book review), 645 terminal, life insurance living benefits packages, 1442 Cancer of the Skin (book review), 1176 pediatric, 1714 Cancer Treatment (book review), 1757 prehistoric, 1289 Canines, photodynamic treatment of spontaneo‘’s cancers with chloro- prevalence, 1982-1987, 165 aluminum sulfonated phthalocyanine, 18 prevention Carboplatin “5-a-Day for Better Health” program, 1538 dose escalation with granulocyte-macrophage colony-stimulating agreements to test foods for, 1050 factor support, ovarian cancer patients, 1748 beta-carotene and, 681, 1110 hypersensitivity reactions to, 1763 cancer mortality and, 1636 with carboplatin dose escalation, ovarian cancer patients, 1748 international meeting, 391 Carcinogenesis: Progress in Clinical and Biological Research (book planning and policy considerations (commentary), 475 review), 876 progress in, 161 Carcinogenesis, rat, diet and, 1261 reading program for low-income women combined with, 1374 Carcinogenicity of dioxins (editorial), 1198 soy products and (commentary), 541 Carcinogens STOP CANCER reorganization, 1140 hemoglobin adducts, urinary mutagenicity, and metabolic phenotype vitamin C and, 396, 547 in active and passive cigarette smokers, 963 promotion of, 238 identification and action of, 161 new technologies, 6 Carcinomas, iiidline, of uncertain histologies, genetic analysis as aid tumor suppressor genes, new prospects for (review), 91 in, 314, 341 radar (traffic) guns and, 1290 Carcinomas of the Head and Neck: Cancer Treatment Research (book rates in Florida, 1704 review), 785 registry, problems in classifying invasive bladder cancer, 429 Case-control studies research canine malignant lymphoma and 2,4-dichlorophenoxyacetic acid agenda for women’s health, 1443 herbicides, 1226 clinical application emphasized by American Association for Can- nested, lung cancer in meat industry, 1337 cer Research, 819 Cells see also specific cell types clinical, poor funding rates, 838 autologous melanoma, lysis by tumor-infiltrating lymphocyctes, clinical, status in U.S., 829 clinical response and, 932 congressional budget hearings, 537 CEM-CCRF human tumor cell line, multidrug resistance assay, 206 information dissemination, 319 division cycle, cdc2, and cancer (editorial), 896 informed consent for use of patient’s cells, 368 gastric carcinoma, p53 gene abnormalities in, 938 Italian program, 1372 HL60, vacuolar H+-adenosine triphosphatase activity in multidrug new frontiers at American Society of Clinical Oncology, 821 resistance in, 1098 progress from 1971 to 1991, 84 hypoxic spin-offs for other diseases, 812, 1508 cytotoxin research (editorial), 156 symptom control studies, importance of, 963 therapeutic advantage in tumors, 178 Statistics review available, 755 informed consent for research use of, 368 surveillance, problems in delineating in situ and invasive bladder malignant lymphoma, effect of in vitro electrical stimulation on pro- cancer (editorial), 384 liferation, 116 survival multidrug resistant, magnetic-affinity cell sorting method, 565 diagnosis and treatment advances during 1971-1991 and, 234 ras-resistant and ras-sensistive, gene expression patterns in, 485 gender differences in, 579 wall skeleton, and monophosphoryl lipid A adjuvant, effect on im- survivors munogenicity of murine B16 melanoma vaccine, 1240 anniversary commemoration for, 1445 Central neryeus system childhood cancer, therapy-related germ cell mutations in, 1643 cancer incidence time trends in Connecticut, 1679 treatment metastases advances during 1971-1991, 234 of breast cancer, tissue polypeptide antigen activity in cerebro- barriers to, 468 spinal fluid as marker of, 779 clinics, unrecognized, danger of, 212 protection from systemic chemotherapy by adrenal cortico- differentiation therapy, 1209 steroids, 648 guidelines, CancerFax, 399 Cervical cancer immunology research and, 388 human papillomavirus and, 160 monoclonal antibodies (editorial), 78 in Australia, serum selenium level and, 292 pregnancy and, 900 Chemoprevention Journal of the National Cancer Institute

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users